⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL82185 | 1.00 | — | — | |
| SCHEMBL1642291 | 0.81 | — | — | |
| SCHEMBL1642290 | 0.81 | — | — | |
| SCHEMBL21708158 | 0.79 | — | — | |
| SCHEMBL21708156 | 0.79 | — | — | |
| SCHEMBL1898470 | 0.79 | — | — | |
| SCHEMBL1898469 | 0.79 | — | — | |
| SCHEMBL3155054 | 0.76 | CASP1 (0.31) | — | |
| SCHEMBL6559551 | 0.76 | — | — | |
| SCHEMBL3155048 | 0.76 | CASP1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 954 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024169178-A1 | LOW-SENSITIZATION PRESSURE-SENSITIVE ADHESIVE FOR MEDICAL DRESSING AND PREPARATION METHOD THEREFOR | 南京斯瑞奇医疗用品有限公司 | 2024-08-22 | — | — | WO | claimed |
| CN-117039180-A | In-situ polymerization semi-solid battery and preparation method thereof | 湖州耀宁固态电池研究院有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-114249635-A | Novel chiral (R) -binaphthol titanium complex and preparation method and application thereof | 山西医科大学 | 2022-03-29 | — | — | CN | claimed |
| CN-106986815-B | Optically active indole spiro pentenone and its derivative and preparation method | 西华师范大学 | 2020-03-24 | — | — | CN | claimed |
| US-9777198-B2 | Method for producing cohesive polyacrylate adhesive compounds with a narrow molar mass distribution | TESA SE (DE) | 2017-10-03 | — | — | US | claimed |
| EP-2780402-B1 | METHOD FOR PRODUCING COHESIVE POLYACRYLATE ADHESIVE COMPOUNDS WITH A NARROW MOLAR MASS DISTRIBUTION | TESA SE (DE) | 2017-08-09 | — | — | EP | claimed |
| EP-2780378-B1 | METHOD FOR PRODUCING NON-COLORED POLYACRYLATE ADHESIVE COMPOUNDS WITH A NARROW MOLAR MASS DISTRIBUTION | TESA SE (DE) | 2017-07-19 | — | — | EP | claimed |
| US-9540458-B2 | Method for producing non-colored polyacrylate adhesive compounds with a narrow molar mass distribution | TESA SE (DE) | 2017-01-10 | — | — | US | claimed |
| US-20140335163-A1 | TARGETED IDURONATE-2-SULFATASE COMPOUNDS | ANGIOCHEM INC. (CA) | 2014-11-13 | — | — | US | claimed |
| US-20140329971-A1 | Method for Producing Cohesive Polyacrylate Adhesive Compounds with a Narrow Molar Mass Distribution | TESA SE (DE) | 2014-11-06 | — | — | US | claimed |
| EP-2785837-A2 | TARGETED ENZYME COMPOUNDS AND USES THEREOF | Angiochem Inc. (CA) | 2014-10-08 | — | — | EP | claimed |
| US-20140288242-A1 | METHOD FOR PRODUCING NON-COLORED POLYACRYLATE ADHESIVE COMPOUNDS WITH A NARROW MOLAR MASS DISTRIBUTION | TESA SE (DE) | 2014-09-25 | — | — | US | claimed |
| US-8512752-B2 | Hyaluronic acid derivatives obtained via “click chemistry” crosslinking | FIDIA FARMACEUTICI S.P.A. (IT) | 2013-08-20 | — | — | US | claimed |
| WO-2013078562-A2 | TARGETED ENZYME COMPOUNDS AND USES THEREOF | ANGIOCHEM INC. (CA) | 2013-06-06 | — | — | WO | claimed |
| US-20100291171-A1 | HYALURONIC ACID DERIVATIVES OBTAINED VIA \"CLICK CHEMISTRY\" CROSSLINKING | FIDIA FARMACEUTICI S.P.A. (IT) | 2010-11-18 | — | — | US | claimed |
| EP-2061816-A1 | HYALURONIC ACID DERIVATIVES OBTAINED VIA \"CLICK CHEMISTRY\" CROSSLINKING | Fidia Farmaceutici S.p.A. (IT) | 2009-05-27 | — | — | EP | claimed |
| WO-2008031525-A1 | HYALURONIC ACID DERIVATIVES OBTAINED VIA 'CLICK CHEMISTRY' CROSSLINKING | FIDIA FARMACEUTICI S.P.A. (IT) | 2008-03-20 | — | — | WO | claimed |
| US-5932752-A | Process for the C-C bond forming reaction using solid acid catalysts | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 1999-08-03 | — | — | US | claimed |
| US-5767295-A | REACTING ALDEHYDE WITH SILANOL-SUBSTITUTED BUTADIENE IN THE PRESENCE OF A LEWIS ACID | KANEKA CORPORATION (JP) | 1998-06-16 | — | — | US | claimed |
| JP-11199563-A | — | — | None | — | — | JP | disclosed |
| JP-9077760-A | — | — | None | — | — | JP | disclosed |
| US-20260138132-A1 | AMBIENT CONTAMINATION IN BREATH ANALYTE DETECTION AND MEASUREMENT | HOUND LABS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260022205-A1 | Polycarbonate Resin, Polycarbonate Resin Composition, Optical Component, and Producing Method for Polycarbonate Resin | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-4262788-B1 | UREA OREXIN RECEPTOR AGONISTS | MERCK SHARP & DOHME LLC (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2025235389-A1 | P53 MODULATORS | NESTED THERAPEUTICS, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| EP-4634393-A1 | VIRAL VECTORS WITH ENGINEERED FUNCTION AND METHODS OF PRODUCTION THEREOF | Lilium Therapeutics Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20250297332-A1 | DEVICES, SYSTEMS, AND METHODS FOR CAPTURING TARGETS | MASSACHUSETTS GEN HOSPITAL (US) | 2025-09-25 | — | — | US | disclosed |
| EP-4601653-A2 | COVALENT COMPOUNDS AND USES THEREOF | The General Hospital Corporation (US) | 2025-08-20 | — | — | EP | disclosed |
| US-12392769-B1 | Ambient contamination in breath analyte detection and measurement | HOUND LABS, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| EP-3350333-B2 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | MODERNATX INC (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20250215615-A1 | METHOD FOR EVALUATING DNA-ENCODED LIBRARY | NISSAN CHEMICAL CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| WO-2025136898-A1 | AGONISTS OF TREM2 ACTIVITY | MERCK SHARP & DOHME LLC (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025128873-A1 | HETEROCYCLIC PYRIDINONE COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE | VIGIL NEUROSCIENCE, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| US-20250186624-A1 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | ARES CAPITAL CORPORATION, AS AGENT | 2025-06-12 | — | — | US | disclosed |
| US-12286724-B1 | Polyester coating composition for electrodeposition and methods of coating a beverage end coil substrate | SWIMC LLC (US) | 2025-04-29 | — | — | US | disclosed |
| US-20250041325-A1 | LIPID-BASED COMPOSITIONS AND METHODS THEREOF | UNITED STATES GOVERNMENT | 2025-02-06 | — | — | US | disclosed |
| EP-4497771-A1 | POLYCARBONATE RESIN, POLYCARBONATE RESIN COMPOSITION, OPTICAL COMPONENT, AND PRODUCTION METHOD FOR POLYCARBONATE RESIN | Asahi Kasei Kabushiki Kaisha (JP) | 2025-01-29 | — | — | EP | disclosed |
| US-20240425632-A1 | COMPOSITIONS INCLUDING FUNCTIONAL GROUPS COUPLED TO SUBSTRATES, AND METHODS OF MAKING THE SAME | ILLUMINA, INC. (US) | 2024-12-26 | — | — | US | disclosed |
| US-20240374169-A1 | CONTINUOUS MONITORING WITH NANO-DIAMOND HYDROGEL IN MICRONEEDLES | THE UNIVERSITY OF CHICAGO | 2024-11-14 | — | — | US | disclosed |
| CN-118927746-A | Environment-friendly prefabricated TPE plastic track material and preparation method thereof | 安徽雄亚塑胶科技有限公司 | 2024-11-12 | — | — | CN | disclosed |
| US-20240360082-A1 | SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS | NOVARTIS AG (CH) | 2024-10-31 | — | — | US | disclosed |
| US-20240360494-A1 | METHODS OF CAPTURING TARGET ANALYTES | 10X GENOMICS, INC. | 2024-10-31 | — | — | US | disclosed |
| US-20240353400-A1 | BIOCOMPATIBLE SURFACE FOR QUANTUM SENSING AND METHODS THEREOF | UNIV CHICAGO (US) | 2024-10-24 | — | — | US | disclosed |
| CN-118812962-A | Environment-friendly flame-retardant low-odor TPV material and preparation method thereof | 安徽雄亚塑胶科技有限公司 | 2024-10-22 | — | — | CN | disclosed |
| US-20240342260-A1 | TISSUE-DIRECTED ANTIBODIES AND METHODS OF USING THE SAME | ZAG BIO INC (US) | 2024-10-17 | — | — | US | disclosed |
| WO-2024215802-A1 | BENZOFURANYL AND BENZOTHIENYL COMPOUNDS AS P53 MODULATORS | NESTED THERAPEUTICS, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| US-12109274-B2 | Polynucleotides containing a stabilizing tail region | MODERNATX, INC. (US) | 2024-10-08 | — | — | US | disclosed |
| US-20240307517-A1 | DEVELOPMENT OF A HIGHLY EFFICIENT SECOND GENERATION FENTANYL-CONJUGATE VACCINE TO TREAT FENTANYL ADDICTION | CORNELL UNIVERSITY (US) | 2024-09-19 | — | — | US | disclosed |
| US-12084708-B1 | Acoustic wave resonator with active shunt capacitance cancellation and systems thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2024-09-10 | — | — | US | disclosed |
| US-12071620-B2 | Polynucleotides containing a morpholino linker | MODERNATX, INC. (US) | 2024-08-27 | — | — | US | disclosed |
| WO-2024169178-A1 | LOW-SENSITIZATION PRESSURE-SENSITIVE ADHESIVE FOR MEDICAL DRESSING AND PREPARATION METHOD THEREFOR | 南京斯瑞奇医疗用品有限公司 | 2024-08-22 | — | — | WO | disclosed |
| US-12060448-B2 | Compositions including functional groups coupled to substrates, and methods of making the same | ILLUMINA, INC. (US) | 2024-08-13 | — | — | US | disclosed |
| US-20240228508-A1 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | INCYTE CORPORATION | 2024-07-11 | — | — | US | disclosed |
| WO-2024145445-A1 | METHODS OF CAPTURING TARGET ANALYTES | 10X GENOMICS, INC. (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024138016-A1 | METHODS AND MATERIALS FOR PERFORMING ELECTROCHEMICAL ASSAYS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024130069-A1 | VIRAL VECTORS WITH ENGINEERED FUNCTION AND METHODS OF PRODUCTION THEREOF | LILIUM THERAPEUTICS INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| EP-4373809-A1 | SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS | Novartis AG (CH) | 2024-05-29 | — | — | EP | disclosed |
| CN-118047805-A | Method for synthesizing Danishefafsky-Diene by palladium catalysis | 南京师范大学 | 2024-05-17 | — | — | CN | disclosed |
| CN-118047805-A | Method for synthesizing Danishefafsky-Diene by palladium catalysis | 南京师范大学 | 2024-05-17 | — | — | CN | disclosed |
| CN-117980292-A | Substituted pyridone compounds for the treatment of orthomyxoviral infections | 诺华股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| WO-2024081739-A2 | COVALENT COMPOUNDS AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2024-04-18 | — | — | WO | disclosed |
| US-20240101555-A1 | UREA OREXIN RECEPTOR AGONISTS | MERCK SHARP & DOHME LLC (US) | 2024-03-28 | — | — | US | disclosed |
| CN-117510306-A | Preparation method of 3-phenanthryl alcohol | 浙江凯普化工有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117486955-A | Non-classical C-glycoside and stereospecific synthesis method and application thereof | 上海交通大学 | 2024-02-02 | — | — | CN | disclosed |
| US-20240033362-A1 | LIPID COMPOSITION FOR THE DELIVERY OF THERAPEUTIC CARGOS | NAT TECH & ENG SOLUTIONS SANDIA LLC (US) | 2024-02-01 | — | — | US | disclosed |
| US-11851442-B2 | Tricyclic fused thiophene derivatives as JAK inhibitors | INCYTE CORPORATION (US) | 2023-12-26 | — | — | US | disclosed |
| US-20230406843-A1 | Progranulin Modulators and Methods of Using the Same | JANSSEN PHARMACEUTICA NV (BE) | 2023-12-21 | — | — | US | disclosed |
| US-20230391795-A1 | MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS | MERCK SHARP & DOHME LLC (US) | 2023-12-07 | — | — | US | disclosed |
| EP-4274857-A1 | COMPOSITIONS INCLUDING FUNCTIONAL GROUPS COUPLED TO SUBSTRATES, AND METHODS OF MAKING THE SAME | Illumina Inc (US) | 2023-11-15 | — | — | EP | disclosed |
| CN-117039180-A | In-situ polymerization semi-solid battery and preparation method thereof | 湖州耀宁固态电池研究院有限公司 | 2023-11-10 | — | — | CN | disclosed |
| US-11806711-B1 | Systems, devices, and methods for fluidic processing of biological or chemical samples using flexible fluidic circuits | HOUND LABS, INC. (US) | 2023-11-07 | — | — | US | disclosed |
| CN-116997547-A | Granulin precursor modulators and methods of use thereof | 阿库达医疗公司 | 2023-11-03 | — | — | CN | disclosed |
| WO-2023212046-A2 | DEVICES, SYSTEMS, AND METHODS FOR CAPTURING TARGETS | THE GENERAL HOSPITAL CORPORATION (US) | 2023-11-02 | — | — | WO | disclosed |
| EP-4262788-A1 | UREA OREXIN RECEPTOR AGONISTS | Merck Sharp & Dohme LLC (US) | 2023-10-25 | — | — | EP | disclosed |
| EP-3613678-B1 | METHODS AND MATERIALS FOR THE FUNCTIONALIZATION OF POLYMERS AND COATINGS INCLUDING FUNCTIONALIZED POLYMER | SWIMC LLC (US) | 2023-10-18 | — | — | EP | disclosed |
| EP-4259623-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | Arkuda Therapeutics (US) | 2023-10-18 | — | — | EP | disclosed |
| US-20230323344-A1 | POLYNUCLEOTIDES CONTAINING A MORPHOLINO LINKER | ARES CAPITAL CORPORATION, AS AGENT | 2023-10-12 | — | — | US | disclosed |
| WO-2023189240-A1 | SURFACE-TREATED BORON NITRIDE, METHOD FOR MANUFACTURING SURFACE-TREATED BORON NITRIDE, RESIN COMPOSITION, AND HEAT-DISSIPATING SUBSTRATE | 株式会社トクヤマ | 2023-10-05 | — | — | WO | disclosed |
| WO-2023182378-A1 | POLYCARBONATE RESIN, POLYCARBONATE RESIN COMPOSITION, OPTICAL COMPONENT, AND PRODUCTION METHOD FOR POLYCARBONATE RESIN | 旭化成株式会社 | 2023-09-28 | — | — | WO | disclosed |
| EP-4236938-A1 | MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS | Merck Sharp & Dohme LLC (US) | 2023-09-06 | — | — | EP | disclosed |
| CN-116710491-A | Composition comprising functional groups coupled to a substrate and method of making the same | 伊鲁米纳公司 | 2023-09-05 | — | — | CN | disclosed |
| US-20230257908-A1 | MODIFIED DNA-ENCODED CHEMICAL LIBRARY AND METHODS RELATED THERETO | TECHNISCHE UNIVERSITAET DORTMUND (DE) | 2023-08-17 | — | — | US | disclosed |
| CN-116600803-A | Macrocyclic urea orexin receptor agonists | 默沙东有限责任公司 | 2023-08-15 | — | — | CN | disclosed |
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2023-07-20 | — | — | US | disclosed |
| US-20230212214-A1 | CLEAVABLE DNA-ENCODED LIBRARY | NISSAN CHEMICAL CORPORATION (JP) | 2023-07-06 | — | — | US | disclosed |
| US-11680946-B1 | Detection of cholinesterase inhibition with microfluidic devices and systems thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2023-06-20 | — | — | US | disclosed |
| WO-2023107574-A2 | LIPID-BASED COMPOSITIONS AND METHODS THEREOF | THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-11674135-B2 | DNA-encoded libraries having encoding oligonucleotide linkages not readable by polymerases | X-CHEM, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| WO-2023095841-A1 | METHOD FOR EVALUATING DNA-ENCODED LIBRARY | 日産化学株式会社 | 2023-06-01 | — | — | WO | disclosed |
| CN-115968506-A | Method for preparing solid hybrid electrolyte without by-product | 蓝色电流股份有限公司 | 2023-04-14 | — | — | CN | disclosed |
| EP-4159766-A1 | CLEAVABLE DNA-ENCODED LIBRARY | Nissan Chemical Corporation (JP) | 2023-04-05 | — | — | EP | disclosed |
| US-20230051031-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON SEPIOLITE FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2023-02-16 | — | — | US | disclosed |
| US-20230034883-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON NATURAL CLAYS FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (60%) (IT) | 2023-02-02 | — | — | US | disclosed |
| WO-2023002443-A1 | SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS | NOVARTIS AG (CH) | 2023-01-26 | — | — | WO | disclosed |
| WO-2023288108-A1 | BIOCOMPATIBLE SURFACE FOR QUANTUM SENSING AND METHODS THEREOF | THE UNIVERSITY OF CHICAGO (US) | 2023-01-19 | — | — | WO | disclosed |
| US-11554369-B2 | Microfluidic package and method of making the same | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2023-01-17 | — | — | US | disclosed |
| EP-3762393-B1 | ALPHA-HYDROXY PHENYLACETIC ACID PHARMACOPHORE OR BIOISOSTERE MCL-1 PROTEIN ANTAGONISTS | AMGEN INC (US) | 2023-01-11 | — | — | EP | disclosed |
| EP-4101930-A1 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | ModernaTX, Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| CN-115461456-A | Cleavable DNA-encoded libraries | 日产化学株式会社 | 2022-12-09 | — | — | CN | disclosed |
| WO-2022240898-A1 | DEVELOPMENT OF A HIGHLY EFFICIENT SECOND GENERATION FENTANYL-CONJUGATE VACCINE TO TREAT FENTANYL ADDICTION | CORNELL UNIVERSITY (US) | 2022-11-17 | — | — | WO | disclosed |
| EP-4076729-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON NATURAL CLAYS FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | Consiglio Nazionale Delle Ricerche (IT) | 2022-10-26 | — | — | EP | disclosed |
| EP-4076730-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON SEPIOLITE FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | Consiglio Nazionale Delle Ricerche (IT) | 2022-10-26 | — | — | EP | disclosed |
| US-11433121-B1 | Lipid composition for the delivery of therapeutic cargos | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2022-09-06 | — | — | US | disclosed |
| US-11434486-B2 | Polynucleotides containing a morpholino linker | MODERNATX, INC. (US) | 2022-09-06 | — | — | US | disclosed |
| CN-111040223-B | Preparation method and application of light diffusant | 唐山偶联硅业有限公司 | 2022-08-19 | — | — | CN | disclosed |
| WO-2022150219-A1 | COMPOSITIONS INCLUDING FUNCTIONAL GROUPS COUPLED TO SUBSTRATES, AND METHODS OF MAKING THE SAME | ILLUMINA, INC. (US) | 2022-07-14 | — | — | WO | disclosed |
| US-20220220242-A1 | COMPOSITIONS INCLUDING FUNCTIONAL GROUPS COUPLED TO SUBSTRATES, AND METHODS OF MAKING THE SAME | ILLUMINA, INC. (US) | 2022-07-14 | — | — | US | disclosed |
| US-11383886-B2 | Methods and materials for the functionalization of polymers and coatings including functionalized polymer | THE SHERWIN-WILLIAMS COMPANY (US) | 2022-07-12 | — | — | US | disclosed |
| WO-2022132696-A1 | UREA OREXIN RECEPTOR AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2022-06-23 | — | — | WO | disclosed |
| US-11366116-B1 | Real time autonomous surveillance of pathogens | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2022-06-21 | — | — | US | disclosed |
| WO-2022125849-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2022-06-16 | — | — | WO | disclosed |
| WO-2022094012-A1 | MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2022-05-05 | — | — | WO | disclosed |
| CN-114249635-A | Novel chiral (R) -binaphthol titanium complex and preparation method and application thereof | 山西医科大学 | 2022-03-29 | — | — | CN | disclosed |
| CN-114249635-A | Novel chiral (R) -binaphthol titanium complex and preparation method and application thereof | 山西医科大学 | 2022-03-29 | — | — | CN | disclosed |
| US-11274105-B2 | Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists | AMGEN INC. (US) | 2022-03-15 | — | — | US | disclosed |
| CN-110283051-B | Octahydro-1, 1' -bi-2-naphthol purification method | 西安近代化学研究所 | 2022-03-15 | — | — | CN | disclosed |
| US-11203592-B2 | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-12-21 | — | — | US | disclosed |
| US-20210387998-A1 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | INCYTE HOLDINGS CORPORATION | 2021-12-16 | — | — | US | disclosed |
| CN-111019316-B | Polycarbonate composition with light diffusion performance, preparation method and application | 宁波坚锋新材料有限公司 | 2021-12-03 | — | — | CN | disclosed |
| WO-2021241528-A1 | CLEAVABLE DNA-ENCODED LIBRARY | 日産化学株式会社 | 2021-12-02 | — | — | WO | disclosed |
| US-11161855-B2 | Tricyclic fused thiophene derivatives as JAK inhibitors | INCYTE CORPORATION (US) | 2021-11-02 | — | — | US | disclosed |
| EP-3350333-B1 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | MODERNATX INC (US) | 2021-10-27 | — | — | EP | disclosed |
| US-20210313616-A1 | BYPRODUCT FREE METHODS FOR SOLID HYBRID ELECTROLYTE | Blue Current, Inc. | 2021-10-07 | — | — | US | disclosed |
| US-20210221806-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE | BRISTOL-MYERS SQUIBB COMPANY | 2021-07-22 | — | — | US | disclosed |
| EP-3851529-A1 | DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES | X-Chem, Inc. (US) | 2021-07-21 | — | — | EP | disclosed |
| WO-2021124097-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON SEPIOLITE FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021124103-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON NATURAL CLAYS FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2021-06-24 | — | — | WO | disclosed |
| EP-3828271-A1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X-Chem, Inc. (US) | 2021-06-02 | — | — | EP | disclosed |
| US-10947349-B2 | Shape-preserving polymeric replication of biological matter | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2021-03-16 | — | — | US | disclosed |
| US-10947237-B2 | Antimicrobial compounds and methods of making and using the same | BioVersys AG (CH) | 2021-03-16 | — | — | US | disclosed |
| US-10933027-B1 | Expanded pore particles and delivery methods thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2021-03-02 | — | — | US | disclosed |
| US-20210047344-A1 | ALPHA-HYDROXY PHENYLACETIC ACID PHARMACOPHORE OR BIOISOSTERE MCL-1 PROTEIN ANTAGONISTS | AMGEN INC. (US) | 2021-02-18 | — | — | US | disclosed |
| EP-3321262-B1 | SERINE/THREONINE KINASE INHIBITORS | ARRAY BIOPHARMA INC (US) | 2021-01-13 | — | — | EP | disclosed |
| EP-3762393-A1 | ALPHA-HYDROXY PHENYLACETIC ACID PHARMACOPHORE OR BIOISOSTERE MCL-1 PROTEIN ANTAGONISTS | Amgen Inc. (US) | 2021-01-13 | — | — | EP | disclosed |
| US-20210002630-A1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X-CHEM, INC. | 2021-01-07 | — | — | US | disclosed |
| US-20200399022-A1 | METHODS AND MATERIALS FOR THE FUNCTIONALIZATION OF POLYMERS AND COATINGS INCLUDING FUNCTIONALIZED POLYMER | SHERWIN WILLIAMS CO (US) | 2020-12-24 | — | — | US | disclosed |
| US-10865409-B2 | Methods for tagging DNA-encoded libraries | X-CHEM, INC. (US) | 2020-12-15 | — | — | US | disclosed |
| EP-3392338-B1 | DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES | X CHEM INC (US) | 2020-12-09 | — | — | EP | disclosed |
| EP-3351631-B1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X CHEM INC (US) | 2020-11-04 | — | — | EP | disclosed |
| US-20200316596-A1 | MICROFLUIDIC PACKAGE AND METHOD OF MAKING THE SAME | NAT TECH & ENG SOLUTIONS SANDIA LLC (US) | 2020-10-08 | — | — | US | disclosed |
| US-10786811-B1 | Detection of active and latent infections with microfluidic devices and systems thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2020-09-29 | — | — | US | disclosed |
| US-10717079-B2 | Microfluidic package and method of making the same | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2020-07-21 | — | — | US | disclosed |
| EP-3185865-B1 | TETRAHYDRONAPTHTYRIDINE DERIVATIVES AS MGLUR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE. | MERCK SHARP & DOHME (US) | 2020-07-15 | — | — | EP | disclosed |
| US-10703540-B2 | Methods and materials for the functionalization of polymers and coatings including functionalized polymer | VALSPAR SOURCING, INC. (US) | 2020-07-07 | — | — | US | disclosed |
| US-20200143903-A1 | METHODS FOR IDENTIFYING COMPOUNDS | MIDCAP FINANCIAL TRUST | 2020-05-07 | — | — | US | disclosed |
| CN-111040223-A | Preparation method and application of light diffusant | 陈志强 | 2020-04-21 | — | — | CN | disclosed |
| CN-111019316-A | Polycarbonate composition with light diffusion performance, preparation method and application | 陈志强 | 2020-04-17 | — | — | CN | disclosed |
| US-20200115507-A1 | SHAPE-PRESERVING POLYMERIC REPLICATION OF BIOLOGICAL MATTER | NAT TECH & ENG SOLUTIONS SANDIA LLC (US) | 2020-04-16 | — | — | US | disclosed |
| US-10618901-B2 | LRRK2 inhibitors for the treatment of Parkinson's disease | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2020-04-14 | — | — | US | disclosed |
| EP-3099695-B1 | COMPOUNDS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2020-04-08 | — | — | EP | disclosed |
| CN-106986815-B | Optically active indole spiro pentenone and its derivative and preparation method | 西华师范大学 | 2020-03-24 | — | — | CN | disclosed |
| EP-2900657-B1 | CYCLIC ETHER PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | HOFFMANN LA ROCHE (CH) | 2020-03-11 | — | — | EP | disclosed |
| EP-3612545-A1 | METHODS FOR IDENTIFYING COMPOUNDS | X-Chem, Inc. (US) | 2020-02-26 | — | — | EP | disclosed |
| EP-3613678-A1 | METHODS AND MATERIALS FOR THE FUNCTIONALIZATION OF POLYMERS AND COATINGS INCLUDING FUNCTIONALIZED POLYMER | Swimc, LLC (US) | 2020-02-26 | — | — | EP | disclosed |
| EP-2970340-B1 | BETA-LACTAMASE INHIBITORS | VENATORX PHARMACEUTICALS INC (US) | 2020-02-12 | — | — | EP | disclosed |
| US-20200040002-A1 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | INCYTE CORPORATION | 2020-02-06 | — | — | US | disclosed |
| EP-3119775-B1 | OXEPAN-2-YL-PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | HOFFMANN LA ROCHE (CH) | 2019-11-06 | — | — | EP | disclosed |
| EP-2691372-B1 | TOTAL SYNTHESIS OF REDOX-ACTIVE 1.4-NAPHTHOQUINONES AND THEIR METABOLITES AND THEIR THERAPEUTIC USE AS ANTIMALARIAL AND SCHISTOMICIDAL AGENTS | CENTRE NAT RECH SCIENT (FR) | 2019-10-16 | — | — | EP | disclosed |
| EP-2814746-B1 | METHODS AND MATERIALS FOR THE FUNCTIONALIZATION OF POLYMERS AND COATINGS INCLUDING FUNCTIONALIZED POLYMER | SWIMC LLC (US) | 2019-09-18 | — | — | EP | disclosed |
| WO-2019173181-A1 | ALPHA-HYDROXY PHENYLACETIC ACID PHARMACOPHORE OR BIOISOSTERE MCL-1 PROTEIN ANTAGONISTS | AMGEN INC. (US) | 2019-09-12 | — | — | WO | disclosed |
| US-10370387-B2 | Tricyclic fused thiophene derivatives as JAK inhibitors | INCYTE HOLDINGS CORPORATION (US) | 2019-08-06 | — | — | US | disclosed |
| US-10294248-B2 | Beta-lactamase inhibitors | VenatoRx Pharmaceuticals, Inc. (US) | 2019-05-21 | — | — | US | disclosed |
| WO-2019074824-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2019-04-18 | — | — | WO | disclosed |
| EP-3116862-B1 | PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS | MERCK SHARP & DOHME (US) | 2019-04-17 | — | — | EP | disclosed |
| US-10261078-B2 | Shear horizontal surface acoustic wave (SH-SAW) resonators and arrays thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2019-04-16 | — | — | US | disclosed |
| US-10233146-B2 | Acetylenic cyanoenones as therapeutics for inflammation and carcinogenesis | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2019-03-19 | — | — | US | disclosed |
| US-20190078087-A1 | POLYNUCLEOTIDES CONTAINING A MORPHOLINO LINKER | ARES CAPITAL CORPORATION, AS AGENT | 2019-03-14 | — | — | US | disclosed |
| EP-3044217-B1 | CYCLOHEXADIENE FULLERENE DERIVATIVES | MERCK PATENT GMBH (DE) | 2019-03-13 | — | — | EP | disclosed |
| US-20180354956-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-12-13 | — | — | US | disclosed |
| US-10138255-B2 | Piperazine derivatives as HIV protease inhibitors | MERCK SHARP & DOHME CORP. (US) | 2018-11-27 | — | — | US | disclosed |
| WO-2018195134-A1 | METHODS FOR IDENTIFYING COMPOUNDS | X-CHEM, INC. (US) | 2018-10-25 | — | — | WO | disclosed |
| EP-3392338-A1 | DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES | X-Chem, Inc. (US) | 2018-10-24 | — | — | EP | disclosed |
| EP-2707365-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-10-17 | — | — | EP | disclosed |
| US-10087186-B2 | Compounds as LRRK2 kinase inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-10-02 | — | — | US | disclosed |
| US-20180273552-A1 | BETA-LACTAMASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH | 2018-09-27 | — | — | US | disclosed |
| US-20180256750-A1 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | MODERNA THERAPEUTICS, INC. (US) | 2018-09-13 | — | — | US | disclosed |
| US-10072003-B2 | Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use | MERCK SHARP & DOHME CORP. | 2018-09-11 | — | — | US | disclosed |
| US-20180250282-A1 | Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1 | LILLY CO ELI (US) | 2018-09-06 | — | — | US | disclosed |
| EP-3351631-A2 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X-Chem, Inc. (US) | 2018-07-25 | — | — | EP | disclosed |
| EP-3350333-A2 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | ModernaTX, Inc. (US) | 2018-07-25 | — | — | EP | disclosed |
| EP-2976340-B1 | CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME (US) | 2018-06-13 | — | — | EP | disclosed |
| US-20180148460-A1 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | INCYTE CORPORATION | 2018-05-31 | — | — | US | disclosed |
| US-20180134654-A1 | ACETYLENIC CYANOENONES AS THERAPEUTICS FOR INFLAMMATION AND CARCINOGENESIS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2018-05-17 | — | — | US | disclosed |
| EP-3321262-A1 | SERINE/THREONINE KINASE INHIBITORS | Array Biopharma, Inc. (US) | 2018-05-16 | — | — | EP | disclosed |
| US-20180127393-A1 | SERINE/THREONINE KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2018-05-10 | — | — | US | disclosed |
| US-9963446-B2 | Oxepan-2-yl-pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | GENENTECH, INC. (US) | 2018-05-08 | — | — | US | disclosed |
| US-9962375-B2 | Methyl-piperidine compounds useful for inhibiting microsomal prostaglandin E2 synthase-1 | ELI LILLY AND COMPANY (US) | 2018-05-08 | — | — | US | disclosed |
| US-20180111889-A1 | METHODS OF MAKING MULTICYCLIC COMPOUNDS USING MULTICOMPONENT/TANDEM REACTION SEQUENCES | BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) | 2018-04-26 | — | — | US | disclosed |
| US-9944658-B2 | Beta-lactamase inhibitors | VenatoRx Pharmaceuticals, Inc. (US) | 2018-04-17 | — | — | US | disclosed |
| EP-2758051-B1 | CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-2748357-B1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X CHEM INC (US) | 2018-04-04 | — | — | EP | disclosed |
| EP-2872680-B1 | DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES | X CHEM INC (US) | 2018-04-04 | — | — | EP | disclosed |
| US-9931323-B2 | Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | GENENTECH, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| EP-1175383-B1 | GLUCOCORTICOID RECEPTOR MODULATORS | PFIZER PROD INC (US) | 2018-03-14 | — | — | EP | disclosed |
| US-20180065966-A1 | Antimicrobial Compounds And Methods Of Making And Using The Same | MELINTA THERAPEUTICS, INC. | 2018-03-08 | — | — | US | disclosed |
| US-9908895-B2 | Tricyclic fused thiophene derivatives as JAK inhibitors | INCYTE CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-20180049984-A1 | Carriers for Plasmid and RNP Delivery in the Treatment of Cancer and Other Disease States | SANDIA CORPORATION | 2018-02-22 | — | — | US | disclosed |
| US-20180028686-A1 | Protocells for Plasmid and RNP Delivery in the Treatment of Cancer and Other Disease States | SANDIA CORPORATION | 2018-02-01 | — | — | US | disclosed |
| EP-2820009-B1 | SERINE/THREONINE KINASE INHIBITORS | ARRAY BIOPHARMA INC (US) | 2018-01-31 | — | — | EP | disclosed |
| EP-3268370-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | Melinta Therapeutics, Inc. (US) | 2018-01-17 | — | — | EP | disclosed |
| US-20180002688-A1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X-CHEM, INC. (US) | 2018-01-04 | — | — | US | disclosed |
| US-20170326128-A1 | Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1 | ELI LILLY AND COMPANY | 2017-11-16 | — | — | US | disclosed |
| EP-3240795-A1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X-Chem, Inc. (US) | 2017-11-08 | — | — | EP | disclosed |
| US-20170313473-A1 | Methods and Materials for the Functionalization of Polymers and Coatings Including Functionalized Polymer | VALSPAR SOURCING, INC. (US) | 2017-11-02 | — | — | US | disclosed |
| US-20170305902-A1 | TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME CORP. (US) | 2017-10-26 | — | — | US | disclosed |
| US-9796708-B2 | Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors | ABBVIE INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-9796668-B2 | Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use | REATA PHARMACEUTICALS, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-9796668-B2 | Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use | REATA PHARMACEUTICALS, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| EP-3230278-A1 | NOVEL METHYL-PIPERIDINE COMPOUNDS USEFUL FOR INHIBITING MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 | Eli Lilly and Company (US) | 2017-10-18 | — | — | EP | disclosed |
| US-9777017-B2 | Tricyclic fused thiophene derivatives as JAK inhibitors | INCYTE HOLDINGS CORPORATION (US) | 2017-10-03 | — | — | US | disclosed |
| US-9777198-B2 | Method for producing cohesive polyacrylate adhesive compounds with a narrow molar mass distribution | TESA SE (DE) | 2017-10-03 | — | — | US | disclosed |
| EP-2780402-B1 | METHOD FOR PRODUCING COHESIVE POLYACRYLATE ADHESIVE COMPOUNDS WITH A NARROW MOLAR MASS DISTRIBUTION | TESA SE (DE) | 2017-08-09 | — | — | EP | disclosed |
| US-9725445-B2 | Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2017-08-08 | — | — | US | disclosed |
| US-20170216840-A1 | MICROFLUIDIC PACKAGE AND METHOD OF MAKING THE SAME | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC | 2017-08-03 | — | — | US | disclosed |
| WO-2017132266-A1 | MICROFLUIDIC PACKAGE AND METHOD OF MAKING THE SAME | SANDIA CORPORATION (US) | 2017-08-03 | — | — | WO | disclosed |
| EP-2758377-B1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-2758377-B1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-2780378-B1 | METHOD FOR PRODUCING NON-COLORED POLYACRYLATE ADHESIVE COMPOUNDS WITH A NARROW MOLAR MASS DISTRIBUTION | TESA SE (DE) | 2017-07-19 | — | — | EP | disclosed |
| US-9708290-B2 | Serine/threonine kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2017-07-18 | — | — | US | disclosed |
| EP-3185865-A1 | TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE | Merck Sharp & Dohme Corp. (US) | 2017-07-05 | — | — | EP | disclosed |
| EP-2912031-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-05-31 | — | — | EP | disclosed |
| US-9650176-B2 | Methods and materials for the functionalization of polymers and coatings including functionalized polymer | VALSPAR SOURCING, INC. (US) | 2017-05-16 | — | — | US | disclosed |
| US-9617244-B2 | Antibacterial quinoline derivatives | JANSSEN PHARMACEUTICA NV (BE) | 2017-04-11 | — | — | US | disclosed |
| WO-2017049286-A1 | POLYNUCLEOTIDES CONTAINING A MORPHOLINO LINKER | MODERNA THERAPEUTICS, INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| WO-2017049275-A2 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | MODERNA THERAPEUTICS, INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| US-20170073354-A1 | PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2017-03-16 | — | — | US | disclosed |
| US-20170052174-A1 | SHEAR HORIZONTAL SURFACE ACOUSTIC WAVE (SH-SAW) RESONATORS AND ARRAYS THEREOF | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC | 2017-02-23 | — | — | US | disclosed |
| EP-2061816-B1 | HYALURONIC ACID DERIVATIVES OBTAINED VIA \"CLICK CHEMISTRY\" CROSSLINKING | FIDIA FARM SPA (IT) | 2017-02-22 | — | — | EP | disclosed |
| US-9561212-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-02-07 | — | — | US | disclosed |
| EP-3119775-A1 | OXEPAN-2-YL-PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F. Hoffmann-La Roche AG (CH) | 2017-01-25 | — | — | EP | disclosed |
| US-20170015668-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-01-19 | — | — | US | disclosed |
| US-9546160-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-01-17 | — | — | US | disclosed |
| US-9543523-B2 | Cyclohexadiene fullerene derivatives | MERCK PATENT GMBH (DE) | 2017-01-10 | — | — | US | disclosed |
| US-9540458-B2 | Method for producing non-colored polyacrylate adhesive compounds with a narrow molar mass distribution | TESA SE (DE) | 2017-01-10 | — | — | US | disclosed |
| US-20170001997-A1 | OXEPAN-2-YL-PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2017-01-05 | — | — | US | disclosed |
| US-20160338999-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-11-24 | — | — | US | disclosed |
| WO-2016184313-A1 | HYDROXYL PURINE COMPOUNDS AND USE THEREOF | 南京明德新药研发股份有限公司 | 2016-11-24 | — | — | WO | disclosed |
| US-9493441-B2 | Acyclic cyanoethylpyrazoles as janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2016-11-15 | — | — | US | disclosed |
| US-9493441-B2 | Acyclic cyanoethylpyrazoles as janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2016-11-15 | — | — | US | disclosed |
| US-9493441-B2 | Acyclic cyanoethylpyrazoles as janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2016-11-15 | — | — | US | disclosed |
| US-20160311806-A1 | 4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-10-27 | — | — | US | disclosed |
| EP-3080104-A1 | 4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV INHIBITORS | Bristol-Myers Squibb Company (US) | 2016-10-19 | — | — | EP | disclosed |
| WO-2016153906-A1 | METHODS OF MAKING MULTICYCLIC COMPOUNDS USING MULTICOMPONENT/TANDEM REACTION SEQUENCES | BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) | 2016-09-29 | — | — | WO | disclosed |
| US-20160280704-A1 | CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2016-09-29 | — | — | US | disclosed |
| EP-2841426-B1 | ANTIBACTERIAL QUINOLINE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2016-09-28 | — | — | EP | disclosed |
| WO-2016145417-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | MELINTA THERAPEUTICS, INC. (US) | 2016-09-15 | — | — | WO | disclosed |
| WO-2016145417-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | MELINTA THERAPEUTICS, INC. (US) | 2016-09-15 | — | — | WO | disclosed |
| EP-2758050-B1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME (US) | 2016-08-31 | — | — | EP | disclosed |
| EP-2758050-B1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME (US) | 2016-08-31 | — | — | EP | disclosed |
| US-9409879-B2 | Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-08-09 | — | — | US | disclosed |
| US-20160213652-A1 | Cyclic Ether Pyrazol-4-YL-Heterocyclyl-Carboxamide Compounds And Methods Of Use | GENENTECH, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| EP-3044217-A1 | CYCLOHEXADIENE FULLERENE DERIVATIVES | Merck Patent GmbH (DE) | 2016-07-20 | — | — | EP | disclosed |
| WO-2016109423-A1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X-CHEM, INC. (US) | 2016-07-07 | — | — | WO | disclosed |
| US-20160193216-A1 | IRAK INHIBITORS AND USES THEREOF | NIMBUS IRIS, INC. | 2016-07-07 | — | — | US | disclosed |
| US-20160193216-A1 | IRAK INHIBITORS AND USES THEREOF | NIMBUS IRIS, INC. | 2016-07-07 | — | — | US | disclosed |
| EP-2403842-B1 | CHIRAL DISULFONIMIDES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2016-06-29 | — | — | EP | disclosed |
| EP-2403842-B1 | CHIRAL DISULFONIMIDES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2016-06-29 | — | — | EP | disclosed |
| WO-2016090495-A1 | TARGETED α-L-IDURONIDASE CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2016-06-16 | — | — | WO | disclosed |
| US-20160145200-A1 | NATURAL PRODUCT ANALOGS INCLUDING AN ANTI-INFLAMMATORY CYANOENONE PHARMACORE AND METHODS OF USE | REATA PHARMACEUTICALS, INC. (US) | 2016-05-26 | — | — | US | disclosed |
| US-20160145200-A1 | NATURAL PRODUCT ANALOGS INCLUDING AN ANTI-INFLAMMATORY CYANOENONE PHARMACORE AND METHODS OF USE | REATA PHARMACEUTICALS, INC. (US) | 2016-05-26 | — | — | US | disclosed |
| US-9340520-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-05-17 | — | — | US | disclosed |
| CN-105566579-A | Preparation method of organic silicon light diffusant | WANG JINMING | 2016-05-11 | — | — | CN | disclosed |
| WO-2016069376-A1 | NOVEL METHYL-PIPERIDINE COMPOUNDS USEFUL FOR INHIBITING MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 | ELI LILLY AND COMPANY (US) | 2016-05-06 | — | — | WO | disclosed |
| US-20160122316-A1 | SERINE/THREONINE KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2016-05-05 | — | — | US | disclosed |
| US-9328099-B2 | Cyanomethylpyrazole carboxamides as janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2016-05-03 | — | — | US | disclosed |
| US-9328099-B2 | Cyanomethylpyrazole carboxamides as janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2016-05-03 | — | — | US | disclosed |
| US-9327281-B2 | Carbon-dioxide compound and catalyst | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-05-03 | — | — | US | disclosed |
| US-9328106-B2 | Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | GENENTECH, INC. (US) | 2016-05-03 | — | — | US | disclosed |
| US-9327281-B2 | Carbon-dioxide compound and catalyst | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-05-03 | — | — | US | disclosed |
| US-20160114057-A1 | MODULAR PROTEIN DRUG CONJUGATE THERAPEUTIC | ZYEWORKS INC. (CA) | 2016-04-28 | — | — | US | disclosed |
| EP-1486489-B1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | DOW AGROSCIENCES LLC (US) | 2016-04-27 | — | — | EP | disclosed |
| WO-2016054225-A1 | PLASMID DELIVERY IN THE TREATMENT OF CANCER AND OTHER DISEASE STATES | STC.UNM (US) | 2016-04-07 | — | — | WO | disclosed |
| US-20160060257-A1 | PYRROLO [2,3-B] PYRIDINE CDK9 KINASE INHIBITORS | ABBVIE INC. (US) | 2016-03-03 | — | — | US | disclosed |
| WO-2016032921-A1 | TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME CORP. (US) | 2016-03-03 | — | — | WO | disclosed |
| US-9259470-B2 | Serine/threonine kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2016-02-16 | — | — | US | disclosed |
| US-20160024109-A1 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | INCYTE HOLDINGS CORPORATION | 2016-01-28 | — | — | US | disclosed |
| US-20160024121-A1 | BETA-LACTAMASE INHIBITORS | VenatoRx Pharmaceuticals, Inc. | 2016-01-28 | — | — | US | disclosed |
| US-20160024121-A1 | BETA-LACTAMASE INHIBITORS | VenatoRx Pharmaceuticals, Inc. | 2016-01-28 | — | — | US | disclosed |
| US-20160015695-A1 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | INCYTE CORPORATION | 2016-01-21 | — | — | US | disclosed |
| EP-2970340-A1 | BETA-LACTAMASE INHIBITORS | Venatorx Pharmaceuticals Inc (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2970278-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | AbbVie Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| US-9233998-B2 | Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use | REATA PHARMACEUTICALS, INC. (US) | 2016-01-12 | — | — | US | disclosed |
| US-9233998-B2 | Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use | REATA PHARMACEUTICALS, INC. (US) | 2016-01-12 | — | — | US | disclosed |
| US-9212190-B2 | IRAK inhibitors and uses thereof | NIMBUS IRIS, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| US-9212190-B2 | IRAK inhibitors and uses thereof | NIMBUS IRIS, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| US-9181271-B2 | Tricyclic fused thiophene derivatives as JAK inhibitors | INCYTE HOLDINGS CORPORATION (US) | 2015-11-10 | — | — | US | disclosed |
| US-20150306590-A1 | CARBON-DIOXIDE COMPOUND AND CATALYST | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150306590-A1 | CARBON-DIOXIDE COMPOUND AND CATALYST | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150290341-A1 | TARGETED IDURONATE-2-SULFATASE COMPOUNDS | Anglachem Inc. (CA) | 2015-10-15 | — | — | US | disclosed |
| WO-2015140189-A1 | OXEPAN-2-YL-PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F. HOFFMANN-LA ROCHE AG (CH) | 2015-09-24 | — | — | WO | disclosed |
| WO-2015135091-A1 | PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2015-09-17 | — | — | WO | disclosed |
| EP-2917221-A1 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | Incyte Corporation (US) | 2015-09-16 | — | — | EP | disclosed |
| US-20150252028-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2015-09-10 | — | — | US | disclosed |
| EP-2912031-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2015-09-02 | — | — | EP | disclosed |
| EP-1516874-B1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | DOW AGROSCIENCES LLC (US) | 2015-08-19 | — | — | EP | disclosed |
| EP-2900657-A1 | CYCLIC ETHER PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F. Hoffmann-La Roche AG (CH) | 2015-08-05 | — | — | EP | disclosed |
| US-20150211002-A1 | DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC | 2015-07-30 | — | — | US | disclosed |
| US-9079869-B2 | Chiral disulfonimides | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2015-07-14 | — | — | US | disclosed |
| US-9079869-B2 | Chiral disulfonimides | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2015-07-14 | — | — | US | disclosed |
| US-9079869-B2 | Chiral disulfonimides | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2015-07-14 | — | — | US | disclosed |
| EP-1540013-B1 | EVOLVING NEW MOLECULAR FUNCTION | HARVARD COLLEGE (US) | 2015-07-08 | — | — | EP | disclosed |
| WO-2015088817-A1 | 4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-06-18 | — | — | WO | disclosed |
| EP-2872680-A1 | DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES | X-Chem, Inc. (US) | 2015-05-20 | — | — | EP | disclosed |
| EP-2673271-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2015-05-06 | — | — | EP | disclosed |
| WO-2015036075-A1 | CYCLOHEXADIENE FULLERENE DERIVATIVES | MERCK PATENT GMBH (DE) | 2015-03-19 | — | — | WO | disclosed |
| US-20150069304-A1 | CYCLOHEXADIENE FULLERENE DERIVATIVES | NANO-C, INC. (US) | 2015-03-12 | — | — | US | disclosed |
| EP-2841426-A1 | ANTIBACTERIAL QUINOLINE DERIVATIVES | Janssen Pharmaceutica N.V. (BE) | 2015-03-04 | — | — | EP | disclosed |
| US-8962608-B2 | Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2015-02-24 | — | — | US | disclosed |
| US-8962608-B2 | Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2015-02-24 | — | — | US | disclosed |
| US-8962608-B2 | Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2015-02-24 | — | — | US | disclosed |
| US-20150051244-A1 | ANTIBACTERIAL QUINOLINE DERIVATIVES | JANSSEN-CILAG (FR) | 2015-02-19 | — | — | US | disclosed |
| US-20150037311-A1 | TARGETED LYSOSOMAL ENZYME COMPOUNDS | ANGIOCHEM INC. (CA) | 2015-02-05 | — | — | US | disclosed |
| US-8937189-B2 | Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives | WAYNE STATE UNIVERSITY (US) | 2015-01-20 | — | — | US | disclosed |
| WO-2015000543-A1 | RARE EARTH METAL-BIS(PERFLUOROALKYL)PHOSPHINATES AS LEWIS ACID CATALYSTS | MERCK PATENT GMBH (DE) | 2015-01-08 | — | — | WO | disclosed |
| WO-2015000543-A1 | RARE EARTH METAL-BIS(PERFLUOROALKYL)PHOSPHINATES AS LEWIS ACID CATALYSTS | MERCK PATENT GMBH (DE) | 2015-01-08 | — | — | WO | disclosed |
| EP-2814746-A1 | METHODS AND MATERIALS FOR THE FUNCTIONALIZATION OF POLYMERS AND COATINGS INCLUDING FUNCTIONALIZED POLYMER | Valspar Sourcing, Inc. (US) | 2014-12-24 | — | — | EP | disclosed |
| WO-2014194428-A1 | TARGETED HEPARAN SULFATASE COMPOUNDS | ANGIOCHEM INC. (CA) | 2014-12-11 | — | — | WO | disclosed |
| US-20140335163-A1 | TARGETED IDURONATE-2-SULFATASE COMPOUNDS | ANGIOCHEM INC. (CA) | 2014-11-13 | — | — | US | disclosed |
| US-20140329971-A1 | Method for Producing Cohesive Polyacrylate Adhesive Compounds with a Narrow Molar Mass Distribution | TESA SE (DE) | 2014-11-06 | — | — | US | disclosed |
| US-20140315762-A1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X-CHEM, INC. (US) | 2014-10-23 | — | — | US | disclosed |
| US-8858618-B2 | Stent | TERUMO KABUSHIKI KAISHA (JP) | 2014-10-14 | — | — | US | disclosed |
| EP-2785837-A2 | TARGETED ENZYME COMPOUNDS AND USES THEREOF | Angiochem Inc. (CA) | 2014-10-08 | — | — | EP | disclosed |
| EP-2785838-A2 | TARGETED LYSOSOMAL ENZYME COMPOUNDS | Angiochem Inc. (CA) | 2014-10-08 | — | — | EP | disclosed |
| WO-2014151958-A1 | BETA-LACTAMASE INHIBITORS | VenatoRx Pharmaceuticals, Inc. (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014151958-A1 | BETA-LACTAMASE INHIBITORS | VenatoRx Pharmaceuticals, Inc. (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014146246-A1 | CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2014-09-25 | — | — | WO | disclosed |
| US-20140288242-A1 | METHOD FOR PRODUCING NON-COLORED POLYACRYLATE ADHESIVE COMPOUNDS WITH A NARROW MOLAR MASS DISTRIBUTION | TESA SE (DE) | 2014-09-25 | — | — | US | disclosed |
| EP-2780378-A1 | METHOD FOR PRODUCING NON-COLORED POLYACRYLATE ADHESIVE COMPOUNDS WITH A NARROW MOLAR MASS DISTRIBUTION | Tesa SE (DE) | 2014-09-24 | — | — | EP | disclosed |
| US-8841464-B2 | Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives | WAYNE STATE UNIVERSITY (US) | 2014-09-23 | — | — | US | disclosed |
| WO-2014139328-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | ABBVIE INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140249127-A1 | SERINE/THREONINE KINASE INHIBITORS | GENENTECH, INC. (US) | 2014-09-04 | — | — | US | disclosed |
| US-20140243309-A1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME LLC | 2014-08-28 | — | — | US | disclosed |
| US-20140243309-A1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME LLC | 2014-08-28 | — | — | US | disclosed |
| US-20140243309-A1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME LLC | 2014-08-28 | — | — | US | disclosed |
| EP-1521733-B1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR | PFIZER PROD INC (US) | 2014-08-20 | — | — | EP | disclosed |
| US-20140228348-A1 | CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME LLC | 2014-08-14 | — | — | US | disclosed |
| US-20140228348-A1 | CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME LLC | 2014-08-14 | — | — | US | disclosed |
| US-20140228358-A1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME LLC | 2014-08-14 | — | — | US | disclosed |
| US-20140228358-A1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME LLC | 2014-08-14 | — | — | US | disclosed |
| US-20140228358-A1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME LLC | 2014-08-14 | — | — | US | disclosed |
| EP-2758050-A1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2014-07-30 | — | — | EP | disclosed |
| EP-2758051-A1 | CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2014-07-30 | — | — | EP | disclosed |
| EP-2758377-A1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2014-07-30 | — | — | EP | disclosed |
| EP-2748357-A1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X-Chem, Inc. (US) | 2014-07-02 | — | — | EP | disclosed |
| EP-2529735-B1 | COMPOSITIONS COMPRISING 4-(HETEROCYCLOALKYL)BENZENE-1,3-DIOL DERIVATIVES WITH TYROSINASE ENZYME INHIBITING ACTIVITY | GALDERMA RES & DEV (FR) | 2014-06-25 | — | — | EP | disclosed |
| EP-1734948-B1 | TRI-SUBSTITUED 2-BENZHYDRYL-5-BENZYLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES | UNIV WAYNE STATE (US) | 2014-06-11 | — | — | EP | disclosed |
| WO-2014082184-A1 | TARGETED IDURONATE-2-SULFATASE COMPOUNDS | ANGIOCHEM INC. (CA) | 2014-06-05 | — | — | WO | disclosed |
| US-8735609-B2 | Bryostatin analogues, synthetic methods and uses | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-05-27 | — | — | US | disclosed |
| WO-2014071031-A1 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | INCYTE CORPORATION (US) | 2014-05-08 | — | — | WO | disclosed |
| US-20140121198-A1 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | INCYTE CORPORATION (US) | 2014-05-01 | — | — | US | disclosed |
| WO-2014065791-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-05-01 | — | — | WO | disclosed |
| US-20140121238-A1 | TOTAL SYNTHESIS OF REDOX-ACTIVE 1.4-NAPHTHOQUINONES AND THEIR METABOLITES AND THEIR THERAPEUTIC USE AS ANTIMALARIAL AND SCHISTOMICIDAL AGENTS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-05-01 | — | — | US | disclosed |
| US-8697715-B2 | Serine/threonine kinase inhibitors | ARRAY BIOPHARMA, INC. (US) | 2014-04-15 | — | — | US | disclosed |
| US-20140088117-A1 | CYCLIC ETHER PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2014-03-27 | — | — | US | disclosed |
| US-20140076768-A1 | Methods and Materials for the Functionalization of Polymers and Coatings Including Functionalized Polymer | VALSPAR SOURCING, INC. (US) | 2014-03-20 | — | — | US | disclosed |
| EP-2707365-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2014-03-19 | — | — | EP | disclosed |
| EP-2393781-B1 | DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS | HOFFMANN LA ROCHE (CH) | 2014-03-12 | — | — | EP | disclosed |
| EP-2393781-B1 | DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS | HOFFMANN LA ROCHE (CH) | 2014-03-12 | — | — | EP | disclosed |
| US-20140058120-A1 | TRI-SUBSTITUTED 2-BENZHYDRYL-5-BENZYLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES | WAYNE STATE UNIVERSITY (US) | 2014-02-27 | — | — | US | disclosed |
| EP-2691372-A1 | TOTAL SYNTHESIS OF REDOX-ACTIVE 1.4-NAPHTHOQUINONES AND THEIR METABOLITES AND THEIR THERAPEUTIC USE AS ANTIMALARIAL AND SCHISTOMICIDAL AGENTS | Centre National De La Recherche Scientifique (FR) | 2014-02-05 | — | — | EP | disclosed |
| US-8642798-B2 | Silacycle compounds and methods of use thereof | THE TRUSTEE OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2014-02-04 | — | — | US | disclosed |
| US-8642798-B2 | Silacycle compounds and methods of use thereof | THE TRUSTEE OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2014-02-04 | — | — | US | disclosed |
| US-8642798-B2 | Silacycle compounds and methods of use thereof | THE TRUSTEE OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2014-02-04 | — | — | US | disclosed |
| WO-2014012010-A1 | DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES | X-CHEM, INC. (US) | 2014-01-16 | — | — | WO | disclosed |
| US-20140012020-A1 | Hepatitis C Virus Inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2014-01-09 | — | — | US | disclosed |
| EP-2673271-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2013-12-18 | — | — | EP | disclosed |
| US-8575208-B2 | Inhibitors of serine proteases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-11-05 | — | — | US | disclosed |
| US-8575152-B2 | Non-steroidal compounds useful as glucocorticoid receptor modulators | MERCK SHARP & DOHME B.V. (NL) | 2013-11-05 | — | — | US | disclosed |
| WO-2013160431-A1 | ANTIBACTERIAL QUINOLINE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2013-10-31 | — | — | WO | disclosed |
| US-8552047-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-10-08 | — | — | US | disclosed |
| EP-1637324-B1 | Color image-forming material and lithographic printing plate precursor | FUJIFILM CORP (JP) | 2013-10-02 | — | — | EP | disclosed |
| US-20130252934-A1 | SERINE/THREONINE KINASE INHIBITORS | GENENTECH, INC. (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130231328-A1 | IRAK INHIBITORS AND USES THEREOF | NIMBUS IRIS, INC. (US) | 2013-09-05 | — | — | US | disclosed |
| US-20130231328-A1 | IRAK INHIBITORS AND USES THEREOF | NIMBUS IRIS, INC. (US) | 2013-09-05 | — | — | US | disclosed |
| EP-2631238-A1 | Spirocyclic inhibitors of serine proteases for the treatment of hcv infections | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-08-28 | — | — | EP | disclosed |
| US-8519159-B2 | Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6-disubstituted pyran derivatives | WAYNE STATE UNIVERSITY (US) | 2013-08-27 | — | — | US | disclosed |
| WO-2013123314-A1 | METHODS AND MATERIALS FOR THE FUNCTIONALIZATION OF POLYMERS AND COATINGS INCLUDING FUNCTIONALIZED POLYMER | VALSPAR SOURCING, INC. (US) | 2013-08-22 | — | — | WO | disclosed |
| US-8513442-B2 | Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions | THE UNIVERSITY OF CHICAGO (US) | 2013-08-20 | — | — | US | disclosed |
| US-8513442-B2 | Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions | THE UNIVERSITY OF CHICAGO (US) | 2013-08-20 | — | — | US | disclosed |
| US-8512752-B2 | Hyaluronic acid derivatives obtained via “click chemistry” crosslinking | FIDIA FARMACEUTICI S.P.A. (IT) | 2013-08-20 | — | — | US | disclosed |
| US-8497385-B2 | Bryostatin analogues, synthetic methods and uses | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-07-30 | — | — | US | disclosed |
| EP-1976381-B1 | TRI-SUBSTITUTED 2-BENZHYDRYL-5-BENZLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES | UNIV WAYNE STATE (US) | 2013-07-24 | — | — | EP | disclosed |
| US-8487099-B2 | Gamma secretase modulators | MERCK SHARP & DOHME CORP. (US) | 2013-07-16 | — | — | US | disclosed |
| US-8487099-B2 | Gamma secretase modulators | MERCK SHARP & DOHME CORP. (US) | 2013-07-16 | — | — | US | disclosed |
| US-8487099-B2 | Gamma secretase modulators | MERCK SHARP & DOHME CORP. (US) | 2013-07-16 | — | — | US | disclosed |
| EP-2603504-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2013-06-19 | — | — | EP | disclosed |
| WO-2013078564-A2 | TARGETED LYSOSOMAL ENZYME COMPOUNDS | ANGIOCHEM INC. (CA) | 2013-06-06 | — | — | WO | disclosed |
| WO-2013078562-A2 | TARGETED ENZYME COMPOUNDS AND USES THEREOF | ANGIOCHEM INC. (CA) | 2013-06-06 | — | — | WO | disclosed |
| WO-2013072120-A1 | METHOD FOR PRODUCING NON-COLORED POLYACRYLATE ADHESIVE COMPOUNDS WITH A NARROW MOLAR MASS DISTRIBUTION | TESA SE (DE) | 2013-05-23 | — | — | WO | disclosed |
| US-20130121957-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2013-05-16 | — | — | US | disclosed |
| US-20130123518-A1 | Bryostatin Analogues, Synthetic Methods and Uses | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-05-16 | — | — | US | disclosed |
| EP-2590968-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | Novartis AG (CH) | 2013-05-15 | — | — | EP | disclosed |
| EP-2013171-B1 | PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER S DISEASE | MERCK SHARP & DOHME (GB) | 2013-05-15 | — | — | EP | disclosed |
| US-20130109682-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | NOVARTIS AG (CH) | 2013-05-02 | — | — | US | disclosed |
| WO-2013056096-A1 | POLYPEPTIDE-OPIOID CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2013-04-18 | — | — | WO | disclosed |
| US-8420637-B2 | Abnormal cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. (US) | 2013-04-16 | — | — | US | disclosed |
| US-8420637-B2 | Abnormal cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. (US) | 2013-04-16 | — | — | US | disclosed |
| WO-2013040863-A1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013043964-A1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013043964-A1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013040863-A1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013043962-A1 | CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013043962-A1 | CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013036810-A1 | METHODS FOR TAGGING DNA-ENCODED LIBRARIES | X-CHEM, INC. (US) | 2013-03-14 | — | — | WO | disclosed |
| US-8389547-B2 | Piperidines and related compounds for the treatment of Alzheimer's disease | MERCK SHARP & DOHME LLC | 2013-03-05 | — | — | US | disclosed |
| US-8372879-B2 | 4-(heterocycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2013-02-12 | — | — | US | disclosed |
| US-20130028859-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2013-01-31 | — | — | US | disclosed |
| WO-2012173504-A2 | METHOD FOR SYNTHESIS OF THE SUBSTITUTED AZETIDINONES AND INTERMEDIATES FOR THEIR SYNTHESIS | Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) | 2012-12-20 | — | — | WO | disclosed |
| EP-2529735-A1 | Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics | Galderma Research & Development (FR) | 2012-12-05 | — | — | EP | disclosed |
| WO-2012154777-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-11-15 | — | — | WO | disclosed |
| US-20120283450-A1 | COMPOUNDS INCLUDING AN ANTI-INFLAMMATORY PHARMACORE AND METHODS OF USE | REATA PHARMACEUTICALS, INC. | 2012-11-08 | — | — | US | disclosed |
| EP-2155757-B1 | NEW PROGESTERONE RECEPTOR MODULATORS | MSD OSS BV (NL) | 2012-10-31 | — | — | EP | disclosed |
| EP-2373310-B1 | NOVEL 4-(HETEROCYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND ALSO IN COSMETICS | GALDERMA RES & DEV (FR) | 2012-10-10 | — | — | EP | disclosed |
| US-8283358-B2 | N-sulfonamido polycyclic pyrazolyl compounds | ELAN PHARMACEUTICALS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| US-8283358-B2 | N-sulfonamido polycyclic pyrazolyl compounds | ELAN PHARMACEUTICALS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| US-8283358-B2 | N-sulfonamido polycyclic pyrazolyl compounds | ELAN PHARMACEUTICALS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| WO-2012131010-A1 | TOTAL SYNTHESIS OF REDOX-ACTIVE 1.4-NAPHTHOQUINONES AND THEIR METABOLITES AND THEIR THERAPEUTIC USE AS ANTIMALARIAL AND SCHISTOMICIDAL AGENTS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012131010-A1 | TOTAL SYNTHESIS OF REDOX-ACTIVE 1.4-NAPHTHOQUINONES AND THEIR METABOLITES AND THEIR THERAPEUTIC USE AS ANTIMALARIAL AND SCHISTOMICIDAL AGENTS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-10-04 | — | — | WO | disclosed |
| US-20120238549-A1 | Nuclear Hormone Receptor Modulators | ABBOTT LABORATORIES (US) | 2012-09-20 | — | — | US | disclosed |
| US-8258329-B2 | Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use | REATA PHARMACEUTICALS, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| WO-2012109080-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-08-16 | — | — | WO | disclosed |
| US-20120195857-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2012-08-02 | — | — | US | disclosed |
| US-20120197385-A1 | STENT | TERUMO KABUSHIKI KAISHA (JP) | 2012-08-02 | — | — | US | disclosed |
| US-8222418-B2 | Piperidines and related compounds for the treatment of dementia | Merck Sharp + Dohme Corp. (US) | 2012-07-17 | — | — | US | disclosed |
| EP-1856097-B1 | PYRIDYL AND PHENYL SUBSTITUTED PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY | SCHERING CORP (US) | 2012-07-11 | — | — | EP | disclosed |
| US-8206914-B2 | Evolving new molecular function | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-06-26 | — | — | US | disclosed |
| US-20120157434-A1 | Antimicrobial heterocyclic compounds for treatment of bacterial infections | CSO of MicuRx Pharmaceuticals, Inc. | 2012-06-21 | — | — | US | disclosed |
| US-20120157434-A1 | Antimicrobial heterocyclic compounds for treatment of bacterial infections | CSO of MicuRx Pharmaceuticals, Inc. | 2012-06-21 | — | — | US | disclosed |
| US-20120107328-A1 | GAMMA SECRETASE MODULATORS | MERCK SHARP & DOHME CORP. | 2012-05-03 | — | — | US | disclosed |
| US-20120107328-A1 | GAMMA SECRETASE MODULATORS | MERCK SHARP & DOHME CORP. | 2012-05-03 | — | — | US | disclosed |
| US-8153809-B2 | Dihydropyridone ureas as P2X7 modulators | ROCHE PALO ALTO LLC (US) | 2012-04-10 | — | — | US | disclosed |
| US-8153809-B2 | Dihydropyridone ureas as P2X7 modulators | ROCHE PALO ALTO LLC (US) | 2012-04-10 | — | — | US | disclosed |
| US-8153809-B2 | Dihydropyridone ureas as P2X7 modulators | ROCHE PALO ALTO LLC (US) | 2012-04-10 | — | — | US | disclosed |
| US-8133885-B2 | Non steroidal glucocorticoid receptor modulators | MERCK SHARP & DOHME CORP. (US) | 2012-03-13 | — | — | US | disclosed |
| US-8127675-B2 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| WO-2012021591-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-02-16 | — | — | WO | disclosed |
| WO-2012004217-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | NOVARTIS AG (CH) | 2012-01-12 | — | — | WO | disclosed |
| EP-2403842-A1 | CHIRAL DISULFONIMIDES | Studiengesellschaft Kohle MbH (DE) | 2012-01-11 | — | — | EP | disclosed |
| US-20120004428-A1 | Tri-Substituted 2-Benzhydryl-5-Benzylamino-Tetrahydro-Pyran-4-OL and 6-Benzhydryl-4-Benzylamino-Tetrahydro-Pyran-3-OL Analogues, and Novel 3,6-Disubstituted Pyran Derivatives | WAYNE STATE UNIVERSITY (US) | 2012-01-05 | — | — | US | disclosed |
| US-20110313150-A1 | CHIRAL DISULFONIMIDES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110313150-A1 | CHIRAL DISULFONIMIDES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110313150-A1 | CHIRAL DISULFONIMIDES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2011-12-22 | — | — | US | disclosed |
| EP-2393781-A1 | DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS | F. Hoffmann-La Roche AG (CH) | 2011-12-14 | — | — | EP | disclosed |
| EP-2158205-B1 | 3,3-SPIROINDOLINONE DERIVATIVES AS ANTICANCER AGENTS | HOFFMANN LA ROCHE (CH) | 2011-12-07 | — | — | EP | disclosed |
| US-8063037-B2 | Progesterone receptor modulators | N. V. ORGANON (NL) | 2011-11-22 | — | — | US | disclosed |
| EP-1917269-B1 | INHIBITORS OF SERINE PROTEASES | VERTEX PHARMA (US) | 2011-10-26 | — | — | EP | disclosed |
| EP-2001848-B1 | PIPERIDINES AND RELATED COMPOUNDS FOR THE TREATMENT OF DEMENTIA | MERCK SHARP & DOHME (GB) | 2011-10-26 | — | — | EP | disclosed |
| EP-2265583-B1 | SPIROINDOLINONE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2011-10-12 | — | — | EP | disclosed |
| EP-2366704-A1 | Inhibitors of serine proteases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-09-21 | — | — | EP | disclosed |
| EP-2364984-A1 | Inhibitors of serine proteases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-09-14 | — | — | EP | disclosed |
| US-8017791-B2 | Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel, 3,6-disubstituted pyran derivatives | WAYNE STATE UNIVERSITY (US) | 2011-09-13 | — | — | US | disclosed |
| US-20110201615-A1 | TRIAZOLE BETA CARBOLINE DERIVATIVES AS ANTI-DIABETIC AGENTS | MERCK SHARP & DOHME CORP. | 2011-08-18 | — | — | US | disclosed |
| EP-2352373-A1 | TRIAZOLE BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS | Merck Sharp & Dohme Corp. (US) | 2011-08-10 | — | — | EP | disclosed |
| US-20110190141-A1 | Evolving New Molecular Function | PRESIDENT AND FELLOWS OF HAVARD COLLEGE (US) | 2011-08-04 | — | — | US | disclosed |
| EP-2346863-A2 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | Elan Pharmaceuticals Inc. (US) | 2011-07-27 | — | — | EP | disclosed |
| EP-2089360-B1 | SPIROINDOLINONE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2011-06-08 | — | — | EP | disclosed |
| US-7915433-B2 | Tri-substituted 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6 disubstituted pyran derivatives | WAYNE STATE UNIVERSITY (US) | 2011-03-29 | — | — | US | disclosed |
| US-7879890-B2 | hydantoin derivatives that can inhibit matrix metalloproteinases and tumor necrosis factor alpha-converting enzyme, to prevent the release of tumor necrosis factor; treatment of septic shock, reperfusion injuries, meningitis, psoriasis, arthritis, inflammatory bowel disease and ankylosing spondylitis | SCHERING CORPORATION (US) | 2011-02-01 | — | — | US | disclosed |
| US-7879890-B2 | hydantoin derivatives that can inhibit matrix metalloproteinases and tumor necrosis factor alpha-converting enzyme, to prevent the release of tumor necrosis factor; treatment of septic shock, reperfusion injuries, meningitis, psoriasis, arthritis, inflammatory bowel disease and ankylosing spondylitis | SCHERING CORPORATION (US) | 2011-02-01 | — | — | US | disclosed |
| WO-2011011665-A1 | HEMI-PHORBOXAZOLE A DERIVATIVES AND METHODS OF THEIR USE | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2011-01-27 | — | — | WO | disclosed |
| EP-2265583-A1 | SPIROINDOLINONE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2010-12-29 | — | — | EP | disclosed |
| US-20100317886-A1 | SYNTHESIS OF ISOTOPICALLY-LABELED FUNCTIONALIZED DIENES | NEW MEXICO HIGHLANDS UNIVERSITY | 2010-12-16 | — | — | US | disclosed |
| US-20100298164-A1 | STRUCTURE-BASED APPROACH TO DESIGN OF INHIBITORS OF PROTEIN-PROCESSIVITY FACTOR INTERACTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2010-11-25 | — | — | US | disclosed |
| US-20100291171-A1 | HYALURONIC ACID DERIVATIVES OBTAINED VIA \"CLICK CHEMISTRY\" CROSSLINKING | FIDIA FARMACEUTICI S.P.A. (IT) | 2010-11-18 | — | — | US | disclosed |
| US-20100280091-A1 | TRI-SUBSTITUTED 2-BENZHYDRYL-5-BENZYLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISBUSTITUTED PYRAN DERIVATIVES | WAYNE STATE UNIVERSITY (US) | 2010-11-04 | — | — | US | disclosed |
| US-20100280262-A1 | BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2010-11-04 | — | — | US | disclosed |
| US-20100272681-A1 | Inhibitors of Serine Proteases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-10-28 | — | — | US | disclosed |
| US-20100267747-A1 | 5-(Arylsulfonyl)-Pyrazolopiperidines | ELAN PHARMACEUTICALS, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| WO-2010099786-A1 | CHIRAL DISULFONIMIDES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2010-09-10 | — | — | WO | disclosed |
| EP-1863803-B1 | SUBSTITUTED PIPERIDINES | NOVARTIS AG (CH) | 2010-09-01 | — | — | EP | disclosed |
| EP-2217604-A1 | GAMMA SECRETASE MODULATORS | Schering Corporation (US) | 2010-08-18 | — | — | EP | disclosed |
| US-7776862-B2 | Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity | SCHERING CORPORATION (US) | 2010-08-17 | — | — | US | disclosed |
| US-7771935-B2 | Evolving new molecular function | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-08-10 | — | — | US | disclosed |
| US-7763739-B2 | bidentante optionally N-containing P-ligands embracing a two-ring-system; for transition metal complexes to be used as catalysts | Evonik Degussa, GmbH (DE) | 2010-07-27 | — | — | US | disclosed |
| US-20100184999-A1 | Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions | THE UNIVERSITY OF CHICAGO | 2010-07-22 | — | — | US | disclosed |
| US-20100184999-A1 | Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions | THE UNIVERSITY OF CHICAGO | 2010-07-22 | — | — | US | disclosed |
| US-20100184758-A1 | BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS | MERCK SHARP & DOHME CORP. | 2010-07-22 | — | — | US | disclosed |
| WO-2010072599-A1 | DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010072599-A1 | DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-07-01 | — | — | WO | disclosed |
| US-20100160388-A1 | DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS | ROCHE PALO ALTO LLC | 2010-06-24 | — | — | US | disclosed |
| US-20100160388-A1 | DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS | ROCHE PALO ALTO LLC | 2010-06-24 | — | — | US | disclosed |
| US-20100160388-A1 | DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS | ROCHE PALO ALTO LLC | 2010-06-24 | — | — | US | disclosed |
| US-20100152446-A1 | Piperidine Derivatives | NERRE THERAPEUTICS LIMITED (GB) | 2010-06-17 | — | — | US | disclosed |
| US-7732609-B2 | 5-(arylsulfonyl)-pyrazolopiperidines | ELAN PHARMACEUTICALS, INC. (US) | 2010-06-08 | — | — | US | disclosed |
| US-7723372-B2 | Spiroindolinone derivatives | HOFFMAN-LA ROCHE INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-7723372-B2 | Spiroindolinone derivatives | HOFFMAN-LA ROCHE INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-7718830-B2 | Abnormal cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718830-B2 | Abnormal cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. (US) | 2010-05-18 | — | — | US | disclosed |
| US-7713989-B2 | Glucocorticoid receptor modulators | DOW ROBERT L | 2010-05-11 | — | — | US | disclosed |
| WO-2010051177-A1 | TRIAZOLE BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS | MERCK SHARP & DOHME CORP. (US) | 2010-05-06 | — | — | WO | disclosed |
| EP-2181996-A1 | Aminopiperidine derivatives | GLAXO GROUP LIMITED (GB) | 2010-05-05 | — | — | EP | disclosed |
| EP-2178537-A1 | BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS | Merck Sharp & Dohme Corp. (US) | 2010-04-28 | — | — | EP | disclosed |
| US-20100081680-A1 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | ELAN PHARMACEUTICALS, INC. | 2010-04-01 | — | — | US | disclosed |
| US-20100081680-A1 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | ELAN PHARMACEUTICALS, INC. | 2010-04-01 | — | — | US | disclosed |
| US-20100081680-A1 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | ELAN PHARMACEUTICALS, INC. | 2010-04-01 | — | — | US | disclosed |
| US-7687495-B2 | Substituted piperidines | SPEEDEL EXPERIMENTA AG (CH) | 2010-03-30 | — | — | US | disclosed |
| US-7687495-B2 | Substituted piperidines | SPEEDEL EXPERIMENTA AG (CH) | 2010-03-30 | — | — | US | disclosed |
| US-7687527-B2 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION (US) | 2010-03-30 | — | — | US | disclosed |
| US-7687527-B2 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION (US) | 2010-03-30 | — | — | US | disclosed |
| WO-2010028213-A2 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | ELAN PHARMACEUTICALS, INC. (US) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010028213-A2 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS | ELAN PHARMACEUTICALS, INC. (US) | 2010-03-11 | — | — | WO | disclosed |
| EP-2158205-A1 | 3,3-SPIROINDOLINONE DERIVATIVES | F. Hoffmann-Roche AG (CH) | 2010-03-03 | — | — | EP | disclosed |
| US-20100048887-A1 | COMPOUNDS INCLUDING AN ANTI-INFLAMMATORY PHARMACORE AND METHODS OF USE | REATA PHARMACEUTICALS, INC. | 2010-02-25 | — | — | US | disclosed |
| US-20100048623-A1 | PIPERIDINES AND RELATED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK SHARP & DOHME LLC | 2010-02-25 | — | — | US | disclosed |
| EP-2155757-A1 | NEW PROGESTERONE RECEPTOR MODULATORS | N.V. Organon (NL) | 2010-02-24 | — | — | EP | disclosed |
| US-7662969-B2 | Efficient aziridination of olefins catalyzed by dirhodium catalysts | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2010-02-16 | — | — | US | disclosed |
| US-20100029628-A1 | 2,4,5-Substituted Piperidines as Renin Inhibitors | NOVARTIS AG (CH) | 2010-02-04 | — | — | US | disclosed |
| US-20100029628-A1 | 2,4,5-Substituted Piperidines as Renin Inhibitors | NOVARTIS AG (CH) | 2010-02-04 | — | — | US | disclosed |
| US-7655809-B2 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2010-02-02 | — | — | US | disclosed |
| US-7655809-B2 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2010-02-02 | — | — | US | disclosed |
| US-7655809-B2 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2010-02-02 | — | — | US | disclosed |
| US-7652012-B2 | Orvepitant maleate; potent and specific antagonists of tachykinins, including substance P and other neurokinins; anxioltic and antidepressant | GLAXO GROUP LIMITED (GB) | 2010-01-26 | — | — | US | disclosed |
| EP-1805141-B1 | PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE | MERCK SHARP & DOHME (GB) | 2010-01-20 | — | — | EP | disclosed |
| US-20100005989-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION | 2010-01-14 | — | — | US | disclosed |
| US-20100010027-A1 | ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE | ALLERGAN, INC. | 2010-01-14 | — | — | US | disclosed |
| US-20100010027-A1 | ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE | ALLERGAN, INC. | 2010-01-14 | — | — | US | disclosed |
| US-20100004222-A1 | Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same | RENOVIS, INC. (US) | 2010-01-07 | — | — | US | disclosed |
| US-20100004222-A1 | Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same | RENOVIS, INC. (US) | 2010-01-07 | — | — | US | disclosed |
| US-20100004222-A1 | Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same | RENOVIS, INC. (US) | 2010-01-07 | — | — | US | disclosed |
| US-7638629-B2 | Piperidines and related compounds for treatment of alzheimer's disease | Merck Sharp & Dohme Ltd, (GB) | 2009-12-29 | — | — | US | disclosed |
| US-7638548-B2 | Spiroindolinone derivatives | HOFFMANN-LA ROCHE INC. (US) | 2009-12-29 | — | — | US | disclosed |
| US-7638548-B2 | Spiroindolinone derivatives | HOFFMANN-LA ROCHE INC. (US) | 2009-12-29 | — | — | US | disclosed |
| EP-2134721-A1 | ANTIMICROBIAL HETEROCYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS | Micurx Pharmaceuticals, Inc. (US) | 2009-12-23 | — | — | EP | disclosed |
| US-7629400-B2 | Image making medium | HYMAN SYDNEY | 2009-12-08 | — | — | US | disclosed |
| US-7618966-B2 | Abnormal Cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. (US) | 2009-11-17 | — | — | US | disclosed |
| US-7618966-B2 | Abnormal Cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. (US) | 2009-11-17 | — | — | US | disclosed |
| US-7612101-B2 | Abnormal cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. (US) | 2009-11-03 | — | — | US | disclosed |
| US-20090270492-A1 | BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2009-10-29 | — | — | US | disclosed |
| WO-2009115425-A1 | SPIROINDOLINONE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-09-24 | — | — | WO | disclosed |
| US-20090239905-A1 | PIPERIDINES AND RELATED COMPOUNDS FOR THE TREATMENT OF DEMENTIA | MERCK SHARP & DOHME LIMITED (GB) | 2009-09-24 | — | — | US | disclosed |
| US-20090239889-A1 | Spiroindolinone Derivatives | LIU JIN-JUN | 2009-09-24 | — | — | US | disclosed |
| US-20090239889-A1 | Spiroindolinone Derivatives | LIU JIN-JUN | 2009-09-24 | — | — | US | disclosed |
| JP-2009191026-A | PROCESS FOR PREPARING OPTICALLY ACTIVE PIPERIDINE DERIVATIVE | JAPAN SCIENCE & TECHNOLOGY AGENCY | 2009-08-27 | — | — | JP | disclosed |
| EP-1661696-B1 | Lithographic printing plate precursor, plate-making method, and lithographic printing method | FUJIFILM CORP (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-20090170875-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION | 2009-07-02 | — | — | US | disclosed |
| US-20090170875-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION | 2009-07-02 | — | — | US | disclosed |
| US-7553833-B2 | Rac-(3S,4R,5S)-6'-chloro-3-(3-chlorophenyl)-1,1',2,2',3,5,6,7-octahydro-5-methoxy-spiro[4H-azepine-4,3'-[3H]-indole]-2',7-dione; anticarcinogenic, -tumor, -proliferative agents; ; murine double minute2 (mdm2) antagonists allows accumulation of p53, cell cycle arrest and/or apoptosis | HOFFMANN-LA ROCHE INC. (US) | 2009-06-30 | — | — | US | disclosed |
| US-7553877-B2 | Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma | PFIZER, INC. (US) | 2009-06-30 | — | — | US | disclosed |
| US-20090163563-A1 | Phorboxazole Compounds and Methods of Their Preparation | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-06-25 | — | — | US | disclosed |
| EP-1754614-B1 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORP (JP) | 2009-06-17 | — | — | EP | disclosed |
| US-20090137586-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION | 2009-05-28 | — | — | US | disclosed |
| US-20090137586-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION | 2009-05-28 | — | — | US | disclosed |
| EP-2061816-A1 | HYALURONIC ACID DERIVATIVES OBTAINED VIA \"CLICK CHEMISTRY\" CROSSLINKING | Fidia Farmaceutici S.p.A. (IT) | 2009-05-27 | — | — | EP | disclosed |
| EP-1270549-B1 | POLYMER-IMMOBILIZED ALPHA-IMINOESTER | JAPAN SCIENCE & TECH AGENCY (JP) | 2009-05-20 | — | — | EP | disclosed |
| WO-2009061699-A1 | GAMMA SECRETASE MODULATORS | SCHERING CORPORATION (US) | 2009-05-14 | — | — | WO | disclosed |
| US-7524605-B2 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| WO-2009052507-A1 | BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2009-04-23 | — | — | WO | disclosed |
| US-7517828-B2 | Chiral broensted acid catalyst for asymmetric synthesis and method of asymmetric synthesis with the catalyst | TOAGOSEI CO., LTD. (JP) | 2009-04-14 | — | — | US | disclosed |
| US-7504424-B2 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION (US) | 2009-03-17 | — | — | US | disclosed |
| US-7504424-B2 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION (US) | 2009-03-17 | — | — | US | disclosed |
| US-20090062262-A1 | NON STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS | N.V. ORGANON (NL) | 2009-03-05 | — | — | US | disclosed |
| US-7498326-B2 | Compounds | GLAXO GROUP LIMITED (GB) | 2009-03-03 | — | — | US | disclosed |
| US-20090054400-A1 | NEW PROGESTERONE RECEPTOR MODULATORS | N.V. ORGANON | 2009-02-26 | — | — | US | disclosed |
| US-7491494-B2 | Evolving new molecular function | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-02-17 | — | — | US | disclosed |
| EP-1853601-B1 | NON STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS | ORGANON NV (NL) | 2009-02-11 | — | — | EP | disclosed |
| US-7488745-B2 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION (US) | 2009-02-10 | — | — | US | disclosed |
| US-7488745-B2 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION (US) | 2009-02-10 | — | — | US | disclosed |
| US-7485631-B2 | Phorboxazole compounds and methods of their preparation | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-02-03 | — | — | US | disclosed |
| US-7485631-B2 | Phorboxazole compounds and methods of their preparation | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-02-03 | — | — | US | disclosed |
| US-7482365-B2 | 4-(2,2-Dimethyl-propylamino)-2-(4-fluoro-2-methyl-phenyl)-piperidine-1-carboxylic acid, [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide; specific antagonists of tachykinins receptor: substance P and neurokinins (NK1); antidepressant, anxiolytic agent; serotonin receptor inhibitor | GLAXO GROUP LIMITED (GB) | 2009-01-27 | — | — | US | disclosed |
| US-7482370-B2 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION (US) | 2009-01-27 | — | — | US | disclosed |
| WO-2009011836-A1 | BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS | MERCK & CO., INC. (US) | 2009-01-22 | — | — | WO | disclosed |
| EP-1924580-B1 | NON-STEROIDAL COMPOUNDS USEFUL AS GLUCOCORTICOID RECEPTOR MODULATORS | ORGANON NV (NL) | 2009-01-21 | — | — | EP | disclosed |
| EP-2013171-A1 | PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER S DISEASE | Merck Sharp & Dohme Limited (GB) | 2009-01-14 | — | — | EP | disclosed |
| WO-2008156656-A2 | METHOD FOR MAKING BIARYL COMPOUNDS, COMPOUNDS MADE BY THE METHOD, AND METHOD FOR THEIR USE | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20080306264-A1 | bidentante optionally N-containing P-ligands embracing a two-ring-system; for transition metal complexes to be used as catalysts | DEGUSSA AG (DE) | 2008-12-11 | — | — | US | disclosed |
| WO-2008141917-A1 | 3,3-SPIROINDOLINONE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2008-11-27 | — | — | WO | disclosed |
| US-20080287421-A1 | 3,3-SPIROINDOLINONE DERIVATIVES | LIU JIN-JUN | 2008-11-20 | — | — | US | disclosed |
| WO-2008135291-A1 | NEW PROGESTERONE RECEPTOR MODULATORS | N.V. ORGANON (NL) | 2008-11-13 | — | — | WO | disclosed |
| EP-1987000-A2 | DIARYL PIPERIDINES AS CB1 MODULATORS | SCHERING CORPORATION (US) | 2008-11-05 | — | — | EP | disclosed |
| EP-1976381-A2 | TRI-SUBSTITUTED 2-BENZHYDRYL-5-BENZLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES | WAYNE STATE UNIVERSITY (US) | 2008-10-08 | — | — | EP | disclosed |
| US-7432268-B2 | 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | SCHERING CORPORATION (US) | 2008-10-07 | — | — | US | disclosed |
| US-7432268-B2 | 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | SCHERING CORPORATION (US) | 2008-10-07 | — | — | US | disclosed |
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-09-18 | — | — | US | disclosed |
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-09-18 | — | — | US | disclosed |
| WO-2008112799-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2008-09-18 | — | — | WO | disclosed |
| WO-2008108988-A1 | ANTIMICROBIAL HETEROCYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS | MICURX PHARMACEUTICALS, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008108988-A1 | ANTIMICROBIAL HETEROCYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS | MICURX PHARMACEUTICALS, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| EP-1957458-A2 | 5-(ARYLSULFONYL)-PYRAZOLOPIPERIDINES | Elan Pharmaceuticals Inc. (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1958634-A2 | Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease | Speedel Experimenta AG (CH) | 2008-08-20 | — | — | EP | disclosed |
| EP-1958634-A2 | Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease | Speedel Experimenta AG (CH) | 2008-08-20 | — | — | EP | disclosed |
| EP-1954132-A2 | AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME | Renovis, Inc. (US) | 2008-08-13 | — | — | EP | disclosed |
| US-20080188459-A1 | Non-Steroidal Compounds Useful as Glucocorticoid Receptor Modulators | N.V. ORGANON (NL) | 2008-08-07 | — | — | US | disclosed |
| EP-1949874-A2 | End sleeve coating for stent delivery | Boston Scientific Limited (BB) | 2008-07-30 | — | — | EP | disclosed |
| US-20080176813-A1 | CARBOCYCLIC NUCLEOSIDES AND PROCESS FOR OBTAINING SUCH | STICHTING REGA VZW (BE) | 2008-07-24 | — | — | US | disclosed |
| US-7402374-B2 | Method for colored image formation | FUJIFILM CORPORATION (JP) | 2008-07-22 | — | — | US | disclosed |
| US-20080171748-A1 | Substituted piperidines | NOVARTIS AG (CH) | 2008-07-17 | — | — | US | disclosed |
| US-20080171748-A1 | Substituted piperidines | NOVARTIS AG (CH) | 2008-07-17 | — | — | US | disclosed |
| EP-1944307-A2 | Synthetic Salicylihalamides, Apicularens and Derivatives Thereof | Board of Regents, The University of Texas System (US) | 2008-07-16 | — | — | EP | disclosed |
| US-20080167468-A1 | using the diastereomeric mixture of Silacycle Compounds for stereoselective synthesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2008-07-10 | — | — | US | disclosed |
| US-20080167468-A1 | using the diastereomeric mixture of Silacycle Compounds for stereoselective synthesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2008-07-10 | — | — | US | disclosed |
| US-20080167478-A1 | Tri-Substituted 2-Benzhydryl-5-Benzlamino-Tetrahydro-Pyran-4-OL and 6-Benzhydryl-4-Benzylamino-Tetrahydro-Pyran-3-OL Analogues, and Novel 3,6-Disubstituted Pyran Derivatives | WAYNE STATE UNIVERSITY (US) | 2008-07-10 | — | — | US | disclosed |
| EP-1935885-A2 | Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. | NEUROGEN CORPORATION (US) | 2008-06-25 | — | — | EP | disclosed |
| US-7390803-B2 | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity | MERCK & CO., INC. (US) | 2008-06-24 | — | — | US | disclosed |
| US-7388070-B1 | Structure-based approach to design of inhibitors of protein-processivity factor interactions | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2008-06-17 | — | — | US | disclosed |
| EP-1619023-B1 | Image forming material | FUJIFILM CORP (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-1204643-B1 | FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION | DOW AGROSCIENCES LLC (US) | 2008-06-04 | — | — | EP | disclosed |
| EP-1924580-A1 | NON-STEROIDAL COMPOUNDS USEFUL AS GLUCOCORTICOID RECEPTOR MODULATORS | N.V. Organon (NL) | 2008-05-28 | — | — | EP | disclosed |
| WO-2008055963-A1 | NOVEL METHOD FOR PRODUCING ORGANIC PHOSPHORUS COMPOUNDS, PHOSPHORUS COMPOUNDS PRODUCED USING SAID METHOD, THE METAL COMPLEXES OF SAID COMPOUNDS, AND USE OF SAME | Rheinisch-Westfälische Technische Hochschule Aachen (DE) | 2008-05-15 | — | — | WO | disclosed |
| US-20080114013-A1 | SPIROINDOLINONE DERIVATIVES | LIU JIN-JUN | 2008-05-15 | — | — | US | disclosed |
| US-20080114013-A1 | SPIROINDOLINONE DERIVATIVES | LIU JIN-JUN | 2008-05-15 | — | — | US | disclosed |
| US-20080108694-A1 | Novel Macrocycles and Uses Thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2008-05-08 | — | — | US | disclosed |
| EP-1666465-B1 | Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor | GLAXO GROUP LTD (GB) | 2008-05-07 | — | — | EP | disclosed |
| EP-1223892-B1 | END SLEEVE COATING FOR STENT DELIVERY SYSTEM | BOSTON SCIENT LTD (BB) | 2008-04-30 | — | — | EP | disclosed |
| EP-1734948-A4 | TRI-SUBSTITUED 2-BENZHYDRYL-5-BENZLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES | UNIV WAYNE STATE (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1908761-A1 | Organic compounds | Speedel Experimenta AG (CH) | 2008-04-09 | — | — | EP | disclosed |
| WO-2008031525-A1 | HYALURONIC ACID DERIVATIVES OBTAINED VIA 'CLICK CHEMISTRY' CROSSLINKING | FIDIA FARMACEUTICI S.P.A. (IT) | 2008-03-20 | — | — | WO | disclosed |
| EP-1897879-A2 | 2,4,5 substituted piperidines as renin inhibitors | Speedel Experimenta AG (CH) | 2008-03-12 | — | — | EP | disclosed |
| EP-1897879-A2 | 2,4,5 substituted piperidines as renin inhibitors | Speedel Experimenta AG (CH) | 2008-03-12 | — | — | EP | disclosed |
| EP-1586461-B1 | Lithographic printing plate precursor | FUJIFILM CORP (JP) | 2008-03-05 | — | — | EP | disclosed |
| EP-1593522-B1 | Lithographic printing plate precursor | FUJIFILM CORP (JP) | 2008-02-27 | — | — | EP | disclosed |
| EP-1669195-B1 | Lithographic printing method | FUJIFILM CORP (JP) | 2008-02-20 | — | — | EP | disclosed |
| US-20080021043-A1 | Piperidines and Related Compounds for Treatment of Alzheimer's Disease | MERCK SHARP & DOHME LTD. (GB) | 2008-01-24 | — | — | US | disclosed |
| US-RE39991-E1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | DOW AGROSCIENCES LLC (US) | 2008-01-01 | — | — | US | disclosed |
| US-RE39991-E1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | DOW AGROSCIENCES LLC (US) | 2008-01-01 | — | — | US | disclosed |
| US-7312212-B2 | Aminopiperidine derivatives | GLAXO GROUP LIMITED (GB) | 2007-12-25 | — | — | US | disclosed |
| EP-1516748-B1 | Lithographic printing plate precursor | FUJIFILM CORP (JP) | 2007-12-19 | — | — | EP | disclosed |
| EP-1602480-B1 | Method for colored image formation | FUJIFILM CORP (JP) | 2007-12-12 | — | — | EP | disclosed |
| EP-1863803-A2 | SUBSTITUTED PIPERIDINES | Speedel Experimenta AG (CH) | 2007-12-12 | — | — | EP | disclosed |
| EP-1584485-B1 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORP (JP) | 2007-12-05 | — | — | EP | disclosed |
| US-20070276005-A1 | TRI-SUBSTITUED 2-BENZHYDRYL 5-BENZLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6 DISUBSTITUTED PYRAN DERIVATIVES | WAYNE STATE UNIVERSITY (US) | 2007-11-29 | — | — | US | disclosed |
| US-20070270485-A1 | Byrostatin analogues, synthetic methods and uses | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2007-11-22 | — | — | US | disclosed |
| EP-1856097-A2 | PYRIDYL AND PHENYL SUBSTITUTED PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY | SCHERING CORPORATION (US) | 2007-11-21 | — | — | EP | disclosed |
| EP-1853601-A1 | NON STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS | N.V. Organon (NL) | 2007-11-14 | — | — | EP | disclosed |
| EP-1557262-B1 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORP (JP) | 2007-11-14 | — | — | EP | disclosed |
| WO-2007125364-A1 | PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER’S DISEASE | MERCK SHARP & DOHME LIMITED (GB) | 2007-11-08 | — | — | WO | disclosed |
| US-20070249670-A1 | Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions Thereof | SMITHKLINE BEECHAM CORPORATION (US) | 2007-10-25 | — | — | US | disclosed |
| US-20070249731-A1 | Abnormal cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. | 2007-10-25 | — | — | US | disclosed |
| US-20070249731-A1 | Abnormal cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. | 2007-10-25 | — | — | US | disclosed |
| US-20070249581-A1 | Abnormal Cannabidiols as agents for lowering intraocular pressure | ALLERGAN, INC. | 2007-10-25 | — | — | US | disclosed |
| US-20070249602-A1 | 4-(1-isopropyl-4-methyl-1,2,5,6-tetra-hydropyridin-2-yl)-5-methylbenzene- 1,3-diol; glaucoma or ocular hypertension | ALLERGAN, INC. | 2007-10-25 | — | — | US | disclosed |
| US-20070249602-A1 | 4-(1-isopropyl-4-methyl-1,2,5,6-tetra-hydropyridin-2-yl)-5-methylbenzene- 1,3-diol; glaucoma or ocular hypertension | ALLERGAN, INC. | 2007-10-25 | — | — | US | disclosed |
| US-20070219218-A1 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION | 2007-09-20 | — | — | US | disclosed |
| US-20070219218-A1 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION | 2007-09-20 | — | — | US | disclosed |
| WO-2007100758-A2 | AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME | RENOVIS, INC. (US) | 2007-09-07 | — | — | WO | disclosed |
| WO-2007100758-A2 | AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME | RENOVIS, INC. (US) | 2007-09-07 | — | — | WO | disclosed |
| US-7265110-B2 | Tetrahydropyran derivatives and their use as therapeutic agents | MERCK SHARP & DOHME LIMITED (GB) | 2007-09-04 | — | — | US | disclosed |
| US-20070203183-A1 | Diaryl piperidines as CB1 modulators | SCHERING CORPORATION | 2007-08-30 | — | — | US | disclosed |
| US-20070203183-A1 | Diaryl piperidines as CB1 modulators | SCHERING CORPORATION | 2007-08-30 | — | — | US | disclosed |
| US-20070203183-A1 | Diaryl piperidines as CB1 modulators | SCHERING CORPORATION | 2007-08-30 | — | — | US | disclosed |
| US-7262299-B2 | Diels-Alder reaction; using zeolite y in exchanged with copper; separated from mixture for reuse | JOHNSON MATTHEY PLC (GB) | 2007-08-28 | — | — | US | disclosed |
| US-7262299-B2 | Diels-Alder reaction; using zeolite y in exchanged with copper; separated from mixture for reuse | JOHNSON MATTHEY PLC (GB) | 2007-08-28 | — | — | US | disclosed |
| US-7256286-B2 | Bryostatin analogues, synthetic methods and uses | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2007-08-14 | — | — | US | disclosed |
| EP-1588858-B1 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORP (JP) | 2007-08-08 | — | — | EP | disclosed |
| EP-1812383-A1 | GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | Smithkline Beecham Corporation (US) | 2007-08-01 | — | — | EP | disclosed |
| WO-2007084319-A2 | DIARYL PIPERIDINES AS CB1 MODULATORS | SCHERING CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |
| WO-2007084319-A2 | DIARYL PIPERIDINES AS CB1 MODULATORS | SCHERING CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |
| WO-2007082292-A2 | TRI-SUBSTITUTED 2-BENZHYDRYL-5-BENZLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES | WAYNE STATE UNIVERSITY (US) | 2007-07-19 | — | — | WO | disclosed |
| EP-1805141-A1 | PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE | MERCK SHARP & DOHME LTD. (GB) | 2007-07-11 | — | — | EP | disclosed |
| US-7241765-B2 | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues | NEUROGEN CORPORATION (US) | 2007-07-10 | — | — | US | disclosed |
| US-20070155753-A1 | 5-(Arylsulfonyl)-Pyrazolopiperidines | ELAN PHARMACEUTICALS, INC. | 2007-07-05 | — | — | US | disclosed |
| US-7230125-B1 | Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions | THE UNIVERSITY OF CHICAGO (US) | 2007-06-12 | — | — | US | disclosed |
| US-7230125-B1 | Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions | THE UNIVERSITY OF CHICAGO (US) | 2007-06-12 | — | — | US | disclosed |
| WO-2007064914-A2 | 5-(ARYLSULFONYL)-PYRAZOLOPIPERIDINES | ELAN PHARMACEUTICALS, INC. (US) | 2007-06-07 | — | — | WO | disclosed |
| US-20070129410-A1 | Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators | PFIZER INC. | 2007-06-07 | — | — | US | disclosed |
| US-20070117805-A1 | Glucocorticoid receptor modulators | PFIZER INC. | 2007-05-24 | — | — | US | disclosed |
| US-7217500-B2 | Color image-forming material and lithographic printing plate precursor | FUJIFILM CORPORATION (JP) | 2007-05-15 | — | — | US | disclosed |
| US-20070099914-A1 | Piperidine Derivatives | NERRE THERAPEUTICS LIMITED (GB) | 2007-05-03 | — | — | US | disclosed |
| US-20070092836-A1 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORPORATION (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1147093-B1 | SUBSTITUTED BICYCLIC DERIVATIVES USEFUL AS ANTICANCER AGENTS | PFIZER PROD INC (US) | 2007-04-11 | — | — | EP | disclosed |
| US-7189713-B2 | Piperidine derivatives | GLAXO GROUP LIMITED (GB) | 2007-03-13 | — | — | US | disclosed |
| US-20070055459-A1 | Structure-based approach to design of protein-processivity factor interactions | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2007-03-08 | — | — | US | disclosed |
| US-20070055459-A1 | Structure-based approach to design of protein-processivity factor interactions | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2007-03-08 | — | — | US | disclosed |
| WO-2007025938-A1 | NON-STEROIDAL COMPOUNDS USEFUL AS GLUCOCORTICOID RECEPTOR MODULATORS | N.V. ORGANON (NL) | 2007-03-08 | — | — | WO | disclosed |
| EP-1444038-B1 | Process for performing an enantioselective catalytic Hetero-Diels-Alder reaction | JOHNSON MATTHEY PLC (GB) | 2007-03-07 | — | — | EP | disclosed |
| WO-2007025307-A2 | INHIBITORS OF SERINE PROTEASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-03-01 | — | — | WO | disclosed |
| EP-1754614-A1 | Lithographic printing plate precursor and lithographic printing method | Fuji Photo Film Co., Ltd. (JP) | 2007-02-21 | — | — | EP | disclosed |
| US-20070021479-A1 | Phorboxazole compounds and methods of their preparation | UNIVERSITY OF PENNSYLVANIA | 2007-01-25 | — | — | US | disclosed |
| US-20070021479-A1 | Phorboxazole compounds and methods of their preparation | UNIVERSITY OF PENNSYLVANIA | 2007-01-25 | — | — | US | disclosed |
| US-20070021611-A1 | Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity | SCHERING CORPORATION | 2007-01-25 | — | — | US | disclosed |
| EP-1745058-A1 | CYCLOOLEFIN PHOSPHINE LIGANDS AND THEIR USE IN CATALYSIS | Degussa GmbH (DE) | 2007-01-24 | — | — | EP | disclosed |
| US-7166593-B2 | Glucocorticoid receptor modulators | PFIZER, INC. (US) | 2007-01-23 | — | — | US | disclosed |
| EP-1518712-B1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO LTD (JP) | 2007-01-10 | — | — | EP | disclosed |
| EP-1423381-B1 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | SCHERING CORP (US) | 2007-01-03 | — | — | EP | disclosed |
| EP-1142708-B1 | Planographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 2006-12-27 | — | — | EP | disclosed |
| EP-1464514-B1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO LTD (JP) | 2006-12-27 | — | — | EP | disclosed |
| EP-1734948-A1 | TRI-SUBSTITUED 2-BENZHYDRYL-5-BENZLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES | WAYNE STATE UNIVERSITY (US) | 2006-12-27 | — | — | EP | disclosed |
| EP-1464513-B1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO LTD (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-7146909-B2 | Image forming material | FUJI PHOTO FILM CO., LTD. (JP) | 2006-12-12 | — | — | US | disclosed |
| US-20060276329-A1 | Asymmetric synthesis catalyst based on chiral brsnsted acid and method of asymmetric synthesis with the catalyst | TOAGOSEI CO., LTD. (JP) | 2006-12-07 | — | — | US | disclosed |
| US-20060276506-A1 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION | 2006-12-07 | — | — | US | disclosed |
| US-20060276506-A1 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION | 2006-12-07 | — | — | US | disclosed |
| US-7138396-B2 | 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | SCHERING CORPORATION (US) | 2006-11-21 | — | — | US | disclosed |
| US-7138406-B2 | Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders | PFIZER, INC. (US) | 2006-11-21 | — | — | US | disclosed |
| US-20060247264-A1 | Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma | PFIZER INC | 2006-11-02 | — | — | US | disclosed |
| EP-1717024-A1 | Lithographic printing plate precursor and lithographic printing method | Fuji Photo Film Co., Ltd. (JP) | 2006-11-02 | — | — | EP | disclosed |
| US-20060229298-A1 | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues | HUTCHISON ALAN | 2006-10-12 | — | — | US | disclosed |
| US-7118848-B2 | Hydrophilic film formed on a metallic base with a roughened surface, and heat conductivity of .05-.5 W/(m middle-dot K) in the direction of its thickness | FUJI PHOTO FILM CO., LTD. (JP) | 2006-10-10 | — | — | US | disclosed |
| WO-2006103277-A2 | 2 , 4 , 5-SUBSTITUTED PIPERIDINES AS RENIN INHIBITORS | SPEEDEL EXPERIMENTA AG (CH) | 2006-10-05 | — | — | WO | disclosed |
| US-7115624-B1 | Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48 | NOVO NORDISK A/S (DK) | 2006-10-03 | — | — | US | disclosed |
| US-20060216642-A1 | Lithographic printing plate precursor and lithographic printing method | FUJI PHOTO FILM CO., LTD. | 2006-09-28 | — | — | US | disclosed |
| US-20060211870-A1 | Efficient aziridination of olefins catalyzed by dirhodium catalysts | THE UNIVERSITY OF MARYLAND COLLEGE PARK (US) | 2006-09-21 | — | — | US | disclosed |
| US-7109213-B2 | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them | GLAXO GROUP LIMITED (GB) | 2006-09-19 | — | — | US | disclosed |
| US-7105547-B2 | Antimicrobial 1-aryl dihydropyridone compounds | PHARMACIA AND UPJOHN COMPANY (US) | 2006-09-12 | — | — | US | disclosed |
| US-20060199812-A1 | Method of conjugating aminothiol containing molecules to vehicles | AMGEN INC. | 2006-09-07 | — | — | US | disclosed |
| WO-2006088919-A2 | PYRIDYL AND PHENYL SUBSTITUTED PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY | SCHERING CORPORATION (US) | 2006-08-24 | — | — | WO | disclosed |
| WO-2006084917-A1 | NON STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS | N.V. ORGANON (NL) | 2006-08-17 | — | — | WO | disclosed |
| EP-1685110-A1 | OCTAHYDROPHENANTHRENE HYDRAZIDE DERIVATIVES USEFUL AS GLUCOCORTICOID RECEPTOR MODULATORS | Pfizer Products Inc. (US) | 2006-08-02 | — | — | EP | disclosed |
| US-7081458-B2 | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues | NEUROGEN CORP. (US) | 2006-07-25 | — | — | US | disclosed |
| US-7078153-B2 | Writable by infrared laser beam exposure; support formed with an anodic oxidation coating having a predetermined density and/or vacancy ratio on a roughened surface of an aluminum substrate. | FUJI PHOTO FILM CO., LTD. (JP) | 2006-07-18 | — | — | US | disclosed |
| US-20060150846-A1 | Lithographic printing method | FUJI PHOTO FILM CO. LTD | 2006-07-13 | — | — | US | disclosed |
| EP-1233956-A4 | BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES | UNIV LELAND STANFORD JUNIOR (US) | 2006-07-05 | — | — | EP | disclosed |
| EP-1540013-A4 | EVOLVING NEW MOLECULAR FUNCTION | HARVARD COLLEGE (US) | 2006-06-28 | — | — | EP | disclosed |
| EP-1279520-B1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO LTD (JP) | 2006-06-21 | — | — | EP | disclosed |
| EP-1669195-A1 | Lithographic printing method | FUJI PHOTO FILM CO., LTD. (JP) | 2006-06-14 | — | — | EP | disclosed |
| US-20060122263-A1 | Tri-substituted 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2006-06-08 | — | — | US | disclosed |
| EP-1666465-A1 | Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor | GLAXO GROUP LIMITED (GB) | 2006-06-07 | — | — | EP | disclosed |
| EP-1427723-B1 | TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | MERCK SHARP & DOHME (GB) | 2006-06-07 | — | — | EP | disclosed |
| US-20060116421-A1 | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity | MERCK SHARP & DOHME CORP. | 2006-06-01 | — | — | US | disclosed |
| US-20060115768-A1 | Lithographic printing plate precursor, plate-making method, and lithographic printing method | FUJI PHOTO FILM CO. LTD | 2006-06-01 | — | — | US | disclosed |
| EP-1247644-B1 | Support for lithographic printing plate and original forme for lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1661696-A1 | Lithographic printing plate precursor, plate-making method, and lithographic printing method | FUJI PHOTO FILM CO., LTD. (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1201649-B1 | Glucocorticoid receptor modulators | PFIZER PROD INC (US) | 2006-05-31 | — | — | EP | disclosed |
| WO-2006052722-A1 | GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | SMITHKLINE BEECHAM CORPORATION (US) | 2006-05-18 | — | — | WO | disclosed |
| WO-2006043064-A1 | PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE | MERCK SHARP & DOHME LIMITED (GB) | 2006-04-27 | — | — | WO | disclosed |
| US-7034035-B2 | Fungicidal mono-, bi-, and tri-cycloheteroalkyl amides and their compositions, methods of use and preparation | DOW AGROSCIENCES LLC (US) | 2006-04-25 | — | — | US | disclosed |
| US-20060069103-A1 | 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | SCHERING CORPORATION | 2006-03-30 | — | — | US | disclosed |
| US-7019026-B1 | Modulators of Protein Tyrosine Phosphatases (PTPases) | NOVO NORDISK A/S (DK) | 2006-03-28 | — | — | US | disclosed |
| EP-1637324-A2 | Color image-forming material and lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2006-03-22 | — | — | EP | disclosed |
| US-20060058287-A1 | Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic | GLAXO GROUP LIMITED (GB) | 2006-03-16 | — | — | US | disclosed |
| US-20060046189-A1 | Color image-forming material and lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. | 2006-03-02 | — | — | US | disclosed |
| EP-1623971-A1 | ASYMMETRIC-SYNTHESIS CATALYST BASED ON CHIRAL BROENSTED ACID AND METHOD OF ASYMMETRIC SYNTHESIS WITH THE CATALYST | TOAGOSEI CO., LTD. (JP) | 2006-02-08 | — | — | EP | disclosed |
| US-20060016356-A1 | Image forming material | FUJI PHOTO FILM CO., LTD. | 2006-01-26 | — | — | US | disclosed |
| EP-1619023-A2 | Image forming material | FUJI PHOTO FILM CO., LTD. (JP) | 2006-01-25 | — | — | EP | disclosed |
| US-20060014755-A1 | 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | MERCK SHARP & DOHME CORP. | 2006-01-19 | — | — | US | disclosed |
| US-20050274945-A1 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2005-12-15 | — | — | US | disclosed |
| EP-1583537-A3 | PIPERIDINE COMPOUNDS AS ANTIBACTERIALS | GLAXO GROUP LIMITED (GB) | 2005-12-14 | — | — | EP | disclosed |
| US-20050271976-A1 | Lithographic printing plate precursor and lithographic printing method | FUJI PHOTO FILM CO., LTD. (JP) | 2005-12-08 | — | — | US | disclosed |
| US-20050271981-A1 | Method for colored image formation | FUJIFILM CORPORATION (JP) | 2005-12-08 | — | — | US | disclosed |
| EP-1602480-A1 | Method for colored image formation | Fuji Photo Film Co., Ltd. (JP) | 2005-12-07 | — | — | EP | disclosed |
| WO-2005108407-A1 | CYCLOOLEFIN PHOSPHINE LIGANDS AND THEIR USE IN CATALYSIS | DEGUSSA AG (DE) | 2005-11-17 | — | — | WO | disclosed |
| EP-1595888-A1 | Cycloolefin phosphine ligands and their use in catalysis | Degussa AG (DE) | 2005-11-16 | — | — | EP | disclosed |
| WO-2005105075-A1 | TRI-SUBSTITUED 2-BENZHYDRYL-5-BENZLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES | WAYNE STATE UNIVERSITY (US) | 2005-11-10 | — | — | WO | disclosed |
| EP-1214325-B1 | MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) | NOVO NORDISK AS (DK) | 2005-11-09 | — | — | EP | disclosed |
| EP-1593522-A1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2005-11-09 | — | — | EP | disclosed |
| US-6962925-B1 | Benzo(C)quinolizine derivatives and their use as 5α-reductases inhibitors | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2005-11-08 | — | — | US | disclosed |
| EP-1472256-B1 | PIPERIDINE DERIVATIVES | GLAXO GROUP LTD (GB) | 2005-11-02 | — | — | EP | disclosed |
| EP-1588858-A2 | Lithographic printing plate precursor and lithographic printing method | Fuji Photo Film Co., Ltd. (JP) | 2005-10-26 | — | — | EP | disclosed |
| US-20050233251-A1 | Lithographic printing plate precursor and lithographic printing method | FUJI PHOTO FILM CO., LTD. | 2005-10-20 | — | — | US | disclosed |
| EP-1586461-A1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2005-10-19 | — | — | EP | disclosed |
| EP-1170149-B1 | Preparation method for lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 2005-10-19 | — | — | EP | disclosed |
| EP-1583537-A2 | PIPERIDINE COMPOUNDS AS ANTIBACTERIALS | GLAXO GROUP LIMITED (GB) | 2005-10-12 | — | — | EP | disclosed |
| EP-1584485-A2 | Lithographic printing plate precursor and lithographic printing method | FUJI PHOTO FILM CO., LTD. (JP) | 2005-10-12 | — | — | EP | disclosed |
| US-6953801-B2 | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues | NEUROGEN CORPORATION (US) | 2005-10-11 | — | — | US | disclosed |
| US-6951878-B2 | Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases) | NOVO NORDISK A/S (DK) | 2005-10-04 | — | — | US | disclosed |
| EP-1201660-B1 | Glucocorticoid receptor modulators | PFIZER PROD INC (US) | 2005-08-31 | — | — | EP | disclosed |
| EP-1066284-B1 | BENZO(C)QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS | APPLIED RESEARCH SYSTEMS (AN) | 2005-08-31 | — | — | EP | disclosed |
| US-6936723-B2 | Synthetic salicylihalamides, apicularens and derivatives thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2005-08-30 | — | — | US | disclosed |
| US-20050182068-A1 | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues | HUTCHISON ALAN (US) | 2005-08-18 | — | — | US | disclosed |
| US-6929895-B2 | Aluminum substrate, an image-recording layer and a hydrophilic film, the aluminum substrate being subjected to an electrochemical surface roughening treatment in an aqueous solution comprising hydrochloric acid and provided with the | FUJI PHOTO FILM CO., LTD. (JP) | 2005-08-16 | — | — | US | disclosed |
| US-20050176715-A1 | Piperidine derivatives | NERRE THERAPEUTICS LIMITED (GB) | 2005-08-11 | — | — | US | disclosed |
| US-6927225-B2 | Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation | DOW AGROSCIENCES LLC (US) | 2005-08-09 | — | — | US | disclosed |
| US-20050170376-A1 | Evolving new molecular function | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2005-08-04 | — | — | US | disclosed |
| US-20050170282-A1 | Lithographic printing plate precursor and lithographic printing method | FUJI PHOTO FILM CO., LTD. | 2005-08-04 | — | — | US | disclosed |
| US-20050171153-A1 | Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases | GLAXO GROUP LIMITED (GB) | 2005-08-04 | — | — | US | disclosed |
| US-6924284-B2 | PARP inhibitors | ICOS CORPORATION (US) | 2005-08-02 | — | — | US | disclosed |
| EP-1557262-A2 | Lithographic printing plate precursor and lithographic printing method | FUJI PHOTO FILM CO., LTD. (JP) | 2005-07-27 | — | — | EP | disclosed |
| US-20050159411-A1 | Aminopiperidine derivatives | GLAXO GROUP LIMITED (GB) | 2005-07-21 | — | — | US | disclosed |
| EP-1554273-A1 | ANTIMICROBIAL 1-ARYL DIHYDROPYRIDONE COMPOUNDS | Pharmacia & Upjohn Company LLC (US) | 2005-07-20 | — | — | EP | disclosed |
| EP-1540013-A2 | EVOLVING NEW MOLECULAR FUNCTION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-06-15 | — | — | EP | disclosed |
| US-6903102-B2 | 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | SCHERING CORPORATION (US) | 2005-06-07 | — | — | US | disclosed |
| WO-2005047254-A1 | OCTAHYDROPHENANTHRENE HYDRAZINDE DERIVATIVES USEFUL AS GLUCOCORTICOID RECEPTOR MODULATORS | PFIZER PRODUCTS INC. (US) | 2005-05-26 | — | — | WO | disclosed |
| US-20050085494-A1 | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them | GLAXO GROUP LIMITED (GB) | 2005-04-21 | — | — | US | disclosed |
| EP-1521733-A1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR | Pfizer Products Inc. (US) | 2005-04-13 | — | — | EP | disclosed |
| US-20050070580-A1 | Antimicrobial 1-aryl dihydropyridone compounds | GORDEEV MIKHAIL FEDOR (US) | 2005-03-31 | — | — | US | disclosed |
| EP-1518712-A2 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2005-03-30 | — | — | EP | disclosed |
| US-20050065162-A1 | MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED 1-BENZYL-4-ARYL PIPERAZINE ANALOGUES | NEUROGEN CORPORATION | 2005-03-24 | — | — | US | disclosed |
| EP-1516875-A1 | FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION | Dow AgroSciences LLC (US) | 2005-03-23 | — | — | EP | disclosed |
| EP-1516748-A1 | Lithographic printing plate precursor | Fuji Photo Film Co., Ltd. (JP) | 2005-03-23 | — | — | EP | disclosed |
| EP-1516874-A1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | Dow AgroSciences LLC (US) | 2005-03-23 | — | — | EP | disclosed |
| US-6852719-B2 | Dietetics; antidiabetic agents; antiinflammatory agents | PFIZER INC. (US) | 2005-02-08 | — | — | US | disclosed |
| EP-1493733-A2 | Fungicidal heterocyclic aromatic amides, their compositions and methods of use | Dow AgroSciences LLC (US) | 2005-01-05 | — | — | EP | disclosed |
| US-6838527-B2 | Polymer-immobilized α-iminoester | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2005-01-04 | — | — | US | disclosed |
| US-20040254184-A1 | Tetrahydropyran derivatives and their use as therapeutic agents | MERCK SHARP & DOHME LTD. (GB) | 2004-12-16 | — | — | US | disclosed |
| EP-1486489-A2 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | Dow AgroSciences LLC (US) | 2004-12-15 | — | — | EP | disclosed |
| EP-1472256-A1 | PIPERIDINE DERIVATIVES | GLAXO GROUP LIMITED (GB) | 2004-11-03 | — | — | EP | disclosed |
| EP-1472222-A1 | PIPERIDYLCARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF TACHYKINIM-MEDIATED DISEASES | GLAXO GROUP LIMITED (GB) | 2004-11-03 | — | — | EP | disclosed |
| EP-1470125-A1 | AMINOPIPERIDINE DERIVATIVES | GLAXO GROUP LIMITED (GB) | 2004-10-27 | — | — | EP | disclosed |
| EP-1470131-A2 | AMINOPIPERIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLAXO GROUP LIMITED (GB) | 2004-10-27 | — | — | EP | disclosed |
| EP-1464513-A1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2004-10-06 | — | — | EP | disclosed |
| EP-1464514-A1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2004-10-06 | — | — | EP | disclosed |
| US-20040180412-A1 | Evolving new molecular function | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2004-09-16 | — | — | US | disclosed |
| EP-0990653-B1 | 2-OXOIMIDAZOLE DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2004-09-15 | — | — | EP | disclosed |
| US-20040176595-A1 | Glucocorticoid receptor modulators | PFIZER, INC. | 2004-09-09 | — | — | US | disclosed |
| US-20040171672-A1 | Synthetic salicylihalamides, apicularens and derivatives thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-09-02 | — | — | US | disclosed |
| JP-2004238368-A | PROCESS FOR AZA DIELS-ALDER REACTION | JAPAN SCIENCE & TECHNOLOGY AGENCY | 2004-08-26 | — | — | JP | disclosed |
| US-20040138262-A1 | Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders | PFIZER INC. | 2004-07-15 | — | — | US | disclosed |
| US-20040132736-A1 | 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | SCHERING CORPORATION | 2004-07-08 | — | — | US | disclosed |
| EP-1427723-A1 | TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | MERCK SHARP & DOHME LTD. (GB) | 2004-06-16 | — | — | EP | disclosed |
| EP-1423381-A1 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | Schering Corporation (US) | 2004-06-02 | — | — | EP | disclosed |
| US-6734209-B2 | MACROCYCLIC LACTONES HAVING ANTI-CANCER ACTIVITY AND VACUOLAR ATPASE INHIBITORY ACTIVITY | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2004-05-11 | — | — | US | disclosed |
| US-20040087588-A1 | Parp inhibitors | ICOS CORPORATION | 2004-05-06 | — | — | US | disclosed |
| WO-2004033449-A1 | ANTIMICROBIAL 1-ARYL DIHYDROPYRIDONE COMPOUNDS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-04-22 | — | — | WO | disclosed |
| US-6716569-B2 | TREATING AN ALUMINUM SUBSTRATE WITH AN AQUEOUS SOLUTION COMPRISING A COMPOUND SELECTED FROM THE GROUP CONSISTING OF NITRITE GROUP-CONTAINING COMPOUND, FLUORINE ATOM-CONTAINING COMPOUND OR PHOSPHORUS ATOM-CONTAINING COMPOUND | FUJI PHOTO FILM CO., LTD. | 2004-04-06 | — | — | US | disclosed |
| US-20040063778-A1 | Synthetic salicylihalamides, apicularens and derivatives thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-04-01 | — | — | US | disclosed |
| US-20040063033-A1 | Press life and an excellent scum resistance during printing | FUJI PHOTO FILM CO., LTD. | 2004-04-01 | — | — | US | disclosed |
| US-6706740-B2 | CONTROLLING, PREVENTION FUNGI INFECTIONS | DOW AGROSCIENCES LLC | 2004-03-16 | — | — | US | disclosed |
| US-20040048864-A1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | INTERDIGITAL TECHNOLOGY CORPORATION | 2004-03-11 | — | — | US | disclosed |
| EP-1038877-B1 | Binaphthol monophosphoric acid derivative and its use | TOSOH CORP (JP) | 2004-03-10 | — | — | EP | disclosed |
| US-6699893-B2 | DIETETICS; ANTIDIABETIC AGENTS; ANTIINFLAMMATROY AGENTS | PFIZER INC | 2004-03-02 | — | — | US | disclosed |
| WO-2004016767-A2 | EVOLVING NEW MOLECULAR FUNCTION | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2004-02-26 | — | — | WO | disclosed |
| US-20040034025-A1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | RICKS MICHAEL J (US) | 2004-02-19 | — | — | US | disclosed |
| EP-1389189-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED 1-BENZYL-4-ARYL PIPERAZINE ANALOGUES | NEUROGEN CORPORATION (US) | 2004-02-18 | — | — | EP | disclosed |
| US-20040014741-A1 | Glucocorticoid receptor modulators | LIU KEVIN K (US) | 2004-01-22 | — | — | US | disclosed |
| WO-2004005229-A1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR | PFIZER PRODUCTS INC. (US) | 2004-01-15 | — | — | WO | disclosed |
| WO-2004002490-A2 | PIPERIDINE COMPOUNDS AS ANTIBACTERIALS | GLAXO GROUP LIMITED (GB) | 2004-01-08 | — | — | WO | disclosed |
| US-6657052-B1 | Labeling DNA or RNA at a specific site consisting of stable precursor, and only becomes reactive upon activation; alkylating only phosphodiester groups; lactonization reaction traps the trialkylphosphate in a stable form. | UNIVERSITY OF ARKANSAS | 2003-12-02 | — | — | US | disclosed |
| US-20030220334-A1 | Byrostatin analogues, synthetic methods and uses | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-11-27 | — | — | US | disclosed |
| US-6638686-B2 | Multilayer; aluminum substarte, photosensitive layer, polymer overcoating | FUJI PHOTO FILM CO., LTD. (JP) | 2003-10-28 | — | — | US | disclosed |
| US-20030186995-A1 | Substituted bicyclic derivatives useful as anticancer agents | PFIZER INC. | 2003-10-02 | — | — | US | disclosed |
| US-20030187147-A1 | Polymer-immobilized alpha-iminoester | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2003-10-02 | — | — | US | disclosed |
| US-6624189-B2 | Anticancer agents | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2003-09-23 | — | — | US | disclosed |
| US-6617348-B1 | Treating or preventing osteoporosis | UT SOUTHWESTERN MEDICAL CENTER | 2003-09-09 | — | — | US | disclosed |
| WO-2003070719-A1 | BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2003-08-28 | — | — | WO | disclosed |
| US-6610721-B2 | Imidazo heterocyclic compounds | NOVO NORDISK A/S (DK) | 2003-08-26 | — | — | US | disclosed |
| WO-2003066635-A1 | PIPERIDINE DERIVATIVES | GLAXO GROUP LIMITED (GB) | 2003-08-14 | — | — | WO | disclosed |
| WO-2003066589-A1 | PIPERIDYLCARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF TACHYKINIM-MEDIATED DISEASES | GLAXO GROUP LIMITED (GB) | 2003-08-14 | — | — | WO | disclosed |
| WO-2003064421-A1 | AMINOPIPERIDINE DERIVATIVES | GLAXO GROUP LIMITED (GB) | 2003-08-07 | — | — | WO | disclosed |
| US-20030148207-A1 | Aluminum substrate, an image-recording layer and a hydrophilic film, the aluminum substrate being subjected to an electrochemical surface roughening treatment in an aqueous solution comprising hydrochloric acid and provided with the | FUJIFILM CORPORATION (JP) | 2003-08-07 | — | — | US | disclosed |
| WO-2003064431-A2 | AMINOPIPERIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLAXO GROUP LIMITED (GB) | 2003-08-07 | — | — | WO | disclosed |
| EP-1328211-A1 | END SLEEVE COATING FOR STENT DELIVERY | Boston Scientific Scimed, Inc. (US) | 2003-07-23 | — | — | EP | disclosed |
| US-6586452-B1 | Plant extracts used as miticides, parasiticides, insecticides and/or anthelmintics | MERCK & CO., INC. | 2003-07-01 | — | — | US | disclosed |
| EP-1106381-B1 | Planographic printing plate precursor | FUJI PHOTO FILM CO LTD (JP) | 2003-06-18 | — | — | EP | disclosed |
| EP-1307439-A2 | SYNTHETIC SALICYLIHALAMIDES, APICULARENS AND DERIVATIVES THEREOF | Board of Regents, The University of Texas System (US) | 2003-05-07 | — | — | EP | disclosed |
| US-20030069267-A1 | Modulators of protein tyrosine phosphatases (PTPases) | MOLLER NIELS PETER HUNDAHL (DK) | 2003-04-10 | — | — | US | disclosed |
| US-6541481-B2 | A quinazoline compound | PFIZER INC | 2003-04-01 | — | — | US | disclosed |
| WO-2003022835-A1 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | SCHERING CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022839-A1 | TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | MERCK SHARP & DOHME LIMITED (GB) | 2003-03-20 | — | — | WO | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
| US-6521622-B1 | Effective against plant pathogens and wood decaying fungi | DOW AGROSCIENCES LLC | 2003-02-18 | — | — | US | disclosed |
| US-20030031860-A1 | Hydrophilic film formed on a metallic base with a roughened surface, and heat conductivity of .05-.5 W/(m middle-dot K) in the direction of its thickness | FUJI PHOTO FILM CO., LTD. | 2003-02-13 | — | — | US | disclosed |
| US-20030022903-A1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | RICKS MICHAEL J (US) | 2003-01-30 | — | — | US | disclosed |
| US-20030022902-A1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | RICKS MICHAEL J (US) | 2003-01-30 | — | — | US | disclosed |
| EP-1279520-A1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2003-01-29 | — | — | EP | disclosed |
| US-20030018012-A1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | RICKS MICHAEL J (US) | 2003-01-23 | — | — | US | disclosed |
| US-20030018052-A1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | RICKS MICHAEL J (US) | 2003-01-23 | — | — | US | disclosed |
| US-6506701-B1 | Polymer-supported quenching reagent covalently reacts with unreacted starting materials | WARNER-LAMBERT COMPANY | 2003-01-14 | — | — | US | disclosed |
| EP-1270549-A1 | POLYMER-IMMOBILIZED ALPHA-IMINOESTER | Japan Science and Technology Corporation (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1268483-A1 | CONDENSED IMIDAZOLES AS HISTAMINE H3 RECEPTOR LIGANDS | NOVO NORDISK A/S (DK) | 2003-01-02 | — | — | EP | disclosed |
| JP-2002356454-A | BINAPHTHOL DERIVATIVE, CHIRAL ZIRCONIUM CATALYST AND ASYMMETRIC HETERO DIELS-ALDER REACTION METHOD | JAPAN SCIENCE & TECHNOLOGY CORP | 2002-12-13 | — | — | JP | disclosed |
| WO-2002094799-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED 1-BENZYL-4-ARYL PIPERAZINE ANALOGUES | NEUROGEN CORPORATION (US) | 2002-11-28 | — | — | WO | disclosed |
| US-20020177578-A1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | RICKS MICHAEL J (US) | 2002-11-28 | — | — | US | disclosed |
| US-20020147336-A1 | Glucocorticoid receptor modulators | DOW ROBERT L (US) | 2002-10-10 | — | — | US | disclosed |
| EP-1247644-A2 | Support for lithographic printing plate and original forme for lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 2002-10-09 | — | — | EP | disclosed |
| US-20020137789-A1 | Byrostatin analogues, synthetic methods and uses | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-09-26 | — | — | US | disclosed |
| US-6447979-B1 | Image recording body | KONICA CORPORATION (JP) | 2002-09-10 | — | — | US | disclosed |
| US-6443980-B1 | CATHETER WITH BONDED SLEEVES; HIGH MOLECULAR WEIGHT VISCOUS HYDROGEL, HYDROPHOBIC OR HYDROPHILIC POLYMER OR PLASTICIZER; AVOIDS USE OF COLLARS, RINGS OR OTHER SECURING DEVICES | SCIMED LIFE SYSTEMS, INC. | 2002-09-03 | — | — | US | disclosed |
| US-6444324-B1 | Lubricated catheter balloon | SCIMED LIFE SYSTEMS, INC. | 2002-09-03 | — | — | US | disclosed |
| EP-1234826-A2 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | Dow AgroSciences LLC (US) | 2002-08-28 | — | — | EP | disclosed |
| EP-1234824-A1 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | Dow AgroSciences LLC (US) | 2002-08-28 | — | — | EP | disclosed |
| EP-1234825-A2 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | Dow AgroSciences LLC (US) | 2002-08-28 | — | — | EP | disclosed |
| EP-1234823-A2 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | Dow AgroSciences LLC (US) | 2002-08-28 | — | — | EP | disclosed |
| EP-1234827-A2 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | Dow AgroSciences LLC (US) | 2002-08-28 | — | — | EP | disclosed |
| EP-1233956-A1 | BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2002-08-28 | — | — | EP | disclosed |
| US-20020107235-A1 | Glucocorticoid receptor modulators | LIU KEVIN K (US) | 2002-08-08 | — | — | US | disclosed |
| EP-1223892-A2 | END SLEEVE COATING FOR STENT DELIVERY SYSTEM | Boston Scientific Limited (BB) | 2002-07-24 | — | — | EP | disclosed |
| US-6410586-B1 | ANTICOAGULANTS; INSULIN RESISTANCE; ANTIALLERGENS | NOVO NORDISK A/S (DK) | 2002-06-25 | — | — | US | disclosed |
| EP-1214325-A1 | MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) | NOVO NORDISK A/S (DK) | 2002-06-19 | — | — | EP | disclosed |
| EP-1214060-A2 | METHOD OF INHIBITING PROTEIN TYROSINE PHOSPHATASE 1B AND/OR T-CELL PROTEIN TYROSINE PHOSPHATASE AND/OR OTHER PTPASES WITH AN ASP RESIDUE AT POSITION 48 | NOVO NORDISK A/S (DK) | 2002-06-19 | — | — | EP | disclosed |
| WO-2002045853-A1 | LEWIS ACID CATALYSIS USING CHIRAL METAL COMPLEXES | DOYLE MICHAEL P (US) | 2002-06-13 | — | — | WO | disclosed |
| US-20020068180-A1 | LUBRICATED CATHETER BALLOON | BOSTON SCIENTIFIC SCIMED, INC. | 2002-06-06 | — | — | US | disclosed |
| WO-2002034165-A1 | END SLEEVE COATING FOR STENT DELIVERY | SCIMED LIFE SYSTEMS, INC. (US) | 2002-05-02 | — | — | WO | disclosed |
| EP-1201649-A1 | Glucocorticoid receptor modulators | Pfizer Products Inc. (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-1201660-A1 | Glucocorticoid receptor modulators | Pfizer Products Inc. (US) | 2002-05-02 | — | — | EP | disclosed |
| US-6380223-B1 | FOR THERAPY OF DISEASES, SUCH AS OBESITY, DIABETES, INFLAMMATION | PFIZER INC. | 2002-04-30 | — | — | US | disclosed |
| US-6369223-B2 | USING CATALYST COMPLEX | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2002-04-09 | — | — | US | disclosed |
| US-20020039702-A1 | Writable by infrared laser beam exposure; support formed with an anodic oxidation coating having a predetermined density and/or vacancy ratio on a roughened surface of an aluminum substrate. | FUJIFILM CORPORATION (JP) | 2002-04-04 | — | — | US | disclosed |
| US-20020039703-A1 | Preparation method for lithographic printing plate | FUJIFILM CORPORATION (JP) | 2002-04-04 | — | — | US | disclosed |
| US-6355660-B1 | HETEROCYCLIC FUNGICIDES SUBSTITUTED WITH AMIDE GROUPS | DOW AGROSCIENCES LLC | 2002-03-12 | — | — | US | disclosed |
| WO-2002012223-A2 | SYNTHETIC SALICYLIHALAMIDES, APICULARENS AND DERIVATIVES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-02-14 | — | — | WO | disclosed |
| EP-1175383-A1 | GLUCOCORTICOID RECEPTOR MODULATORS | Pfizer Products Inc. (US) | 2002-01-30 | — | — | EP | disclosed |
| US-20020004602-A1 | Asymmetric cycloaddition reactions | JACOBSEN ERIC N (US) | 2002-01-10 | — | — | US | disclosed |
| EP-1170149-A2 | Preparation method for lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 2002-01-09 | — | — | EP | disclosed |
| US-6331186-B1 | End sleeve coating for stent delivery | SCIMED LIFE SYSTEMS, INC. | 2001-12-18 | — | — | US | disclosed |
| US-20010049385-A1 | Imidazo heterocyclic compounds | HIGH POINT PHARMACEUTICALS, LLC | 2001-12-06 | — | — | US | disclosed |
| US-20010041305-A1 | Multilayer; aluminum substarte, photosensitive layer, polymer overcoating | FUJIFILM CORPORATION (JP) | 2001-11-15 | — | — | US | disclosed |
| US-20010034351-A1 | Substituted bicyclic derivatives useful as anticancer agents | KATH JOHN CHARLES (US) | 2001-10-25 | — | — | US | disclosed |
| EP-1147093-A1 | SUBSTITUTED BICYCLIC DERIVATIVES USEFUL AS ANTICANCER AGENTS | Pfizer Products Inc. (US) | 2001-10-24 | — | — | EP | disclosed |
| US-6306959-B1 | Rapid purification by polymer supported quench | WARNER LAMBERT COMPANY | 2001-10-23 | — | — | US | disclosed |
| EP-1142708-A1 | Planographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001068651-A1 | CONDENSED IMIDAZOLES AS HISTAMINE H3 RECEPTOR LIGANDS | NOVO NORDISK A/S (DK) | 2001-09-20 | — | — | WO | disclosed |
| US-6284764-B1 | ANTIPROLIFERATIVE AGENT | PFIZER INC. | 2001-09-04 | — | — | US | disclosed |
| US-6274745-B1 | CATALYST | TOSOH CORPORATION (JP) | 2001-08-14 | — | — | US | disclosed |
| US-6265228-B1 | REACTING AT LEAST ONE STARTING COMPOUND ATTACHED TO SOLID SUPPORT WITH SPECIFIC PRIMARY OR SECONDARY AMINE IN PRESENCE OF CARBOXYLIC ACID ACTIVATING AGENT TO PRODUCE DIACETOXY AMIDES, THEN TREATING WITH HYDRAZINE TO PRODUCE LIBRARY | PHARMACOPEIA, INC. | 2001-07-24 | — | — | US | disclosed |
| US-6262044-B1 | CONTAINING AN AMIDE-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE RING | NOVO NORDISK A/S (DK) | 2001-07-17 | — | — | US | disclosed |
| US-6258825-B1 | ANALGESIC, A RELIEVER AGAINST TOLERANCE TO A NARCOTIC ANALGESIC REPRESENTED BY MORPHINE, REMEDY FOR PARKINSONISM, A REMEDY FOR CHOREA, AN ANTIDEPRESSANT, A REMEDY FOR DIABETES INSIPIDUS, A REMEDY FOR POLYURIA, OR HYPOTENSION | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2001-07-10 | — | — | US | disclosed |
| EP-1106381-A1 | Planographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2001-06-13 | — | — | EP | disclosed |
| WO-2001040214-A1 | BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2001-06-07 | — | — | WO | disclosed |
| WO-2001034219-A2 | END SLEEVE COATING FOR STENT DELIVERY SYSTEM | SCIMED LIFE SYSTEMS, INC. (US) | 2001-05-17 | — | — | WO | disclosed |
| US-6211370-B1 | REACTING A DIENOPHILE WITH A 1,3-DIENE | HARVARD UNIVERSITY | 2001-04-03 | — | — | US | disclosed |
| WO-2001019831-A1 | MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) | NOVO NORDISK A/S (DK) | 2001-03-22 | — | — | WO | disclosed |
| WO-2001017516-A2 | METHOD OF INHIBITING PROTEIN TYROSINE PHOSPHATASE 1B AND/OR T-CELL PROTEIN TYROSINE PHOSPHATASE AND/OR OTHER PTPASES WITH AN ASP RESIDUE AT POSITION 48 | NOVO NORDISK A/S (DK) | 2001-03-15 | — | — | WO | disclosed |
| EP-1080095-A1 | MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) | NOVO NORDISK A/S (DK) | 2001-03-07 | — | — | EP | disclosed |
| EP-1080068-A1 | MODULATORS OF PROTEIN TYROSINE PHOSPHATASES | Novo Nordisk A/S (DK) | 2001-03-07 | — | — | EP | disclosed |
| EP-1066284-A1 | BENZO C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS | Applied Research Systems ARS Holding N.V. (AN) | 2001-01-10 | — | — | EP | disclosed |
| WO-2000066522-A1 | GLUCOCORTICOID RECEPTOR MODULATORS | PFIZER PRODUCTS INC. (US) | 2000-11-09 | — | — | WO | disclosed |
| US-6130340-A | CATALYST SELECTIVITY; DRUG CHEMICAL INTERMEDIATES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-10-10 | — | — | US | disclosed |
| EP-1038877-A1 | Binaphthol monophosphoric acid derivative and its use | Tosoh Corporation (JP) | 2000-09-27 | — | — | EP | disclosed |
| WO-2000053545-A1 | PROCESS FOR THE SYNTHESIS OF DIHYDROPYRIDONES | AXYS PHARMACEUTICALS, INC. (US) | 2000-09-14 | — | — | WO | disclosed |
| WO-2000050365-A1 | ASYMMETRIC CYCLOADDITION REACTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-08-31 | — | — | WO | disclosed |
| US-6107503-A | WHERE ZIRCONIUM (IV) IS AN ACTIVE CENTRAL ATOM OF THE CATALYST AND IS BONDED VIA OXYGEN ATOMS TO TWO MOLECULES OF OPTICALLY ACTIVE BINAPHTHYL; MAKING OPTICALLY ACTIVE BETA-AMINOESTERS, BETA-HYDRAZINOESTERS, AND PIPERIDINES | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2000-08-22 | — | — | US | disclosed |
| WO-2000044728-A1 | SUBSTITUTED BICYCLIC DERIVATIVES USEFUL AS ANTICANCER AGENTS | PFIZER PRODUCTS INC. (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000039055-A1 | RAPID PURIFICATION BY POLYAROMATIC QUENCH REAGENTS | WARNER-LAMBERT COMPANY (US) | 2000-07-06 | — | — | WO | disclosed |
| EP-0990653-A1 | 2-OXOIMIDAZOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2000-04-05 | — | — | EP | disclosed |
| US-5976894-A | FOR SCREENING BIOASSAYS TO DISCOVER BIOLOGICALLY ACTIVE MEMBERS | PHARMACOPEIA, INC. (US) | 1999-11-02 | — | — | US | disclosed |
| WO-1999046267-A1 | MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) | NOVO NORDISK A/S (DK) | 1999-09-16 | — | — | WO | disclosed |
| WO-1999046237-A1 | MODULATORS OF PROTEIN TYROSINE PHOSPHATASES | NOVO NORDISK A/S (DK) | 1999-09-16 | — | — | WO | disclosed |
| US-5932752-A | Process for the C-C bond forming reaction using solid acid catalysts | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 1999-08-03 | — | — | US | disclosed |
| JP-H11199563-A | PRODUCTION OF OPTICALLY ACTIVE PIPERIDINES | JAPAN SCIENCE & TECHNOLOGY CORP | 1999-07-27 | — | — | JP | disclosed |
| WO-1999036375-A1 | ASYMMETRIC CYCLOADDITION REACTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-07-22 | — | — | WO | disclosed |
| WO-1999033828-A1 | BENZO[C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 1999-07-08 | — | — | WO | disclosed |
| US-5874432-A | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof | SANOFI (FR) | 1999-02-23 | — | — | US | disclosed |
| EP-0896590-A1 | RAPID PURIFICATION BY POLYMER SUPPORTED QUENCH | WARNER-LAMBERT COMPANY (US) | 1999-02-17 | — | — | EP | disclosed |
| US-5767295-A | REACTING ALDEHYDE WITH SILANOL-SUBSTITUTED BUTADIENE IN THE PRESENCE OF A LEWIS ACID | KANEKA CORPORATION (JP) | 1998-06-16 | — | — | US | disclosed |
| US-5736523-A | ADMINISTERING TO THE MAMMAL SUFFERING FROM CANCER | BIOCHEM PHARMA INC. (CA) | 1998-04-07 | — | — | US | disclosed |
| US-5719139-A | BACTERICIDES | ZENECA LIMITED (GB) | 1998-02-17 | — | — | US | disclosed |
| US-5708168-A | FOR TREATING OR PREVENTING NEURONAL LOSS | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) | 1998-01-13 | — | — | US | disclosed |
| WO-1997042230-A1 | RAPID PURIFICATION BY POLYMER SUPPORTED QUENCH | WARNER-LAMBERT COMPANY (US) | 1997-11-13 | — | — | WO | disclosed |
| US-5650422-A | TREATMENT OF EMPHYSEMA, ARTHRITIS OR PANCREATITIS | SANOFI (FR) | 1997-07-22 | — | — | US | disclosed |
| JP-H0977760-A | PRODUCTION OF 2-SUBSTITUTED OPTICALLY ACTIVE 2,3-DIHYDRO-4H-PYRAN-4-ONE | KANEGAFUCHI CHEM IND CO LTD | 1997-03-25 | — | — | JP | disclosed |
| US-5606037-A | Processes antineoplastic heteronaphthoquinones | BIOCHEM PHARMA INC. (CA) | 1997-02-25 | — | — | US | disclosed |
| US-5597931-A | Total synthesis of taxol and analogues thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1997-01-28 | — | — | US | disclosed |
| US-5596012-A | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof | STERLING WINTHROP INC. (US) | 1997-01-21 | — | — | US | disclosed |
| WO-1996034862-A1 | TOTAL SYNTHESIS OF TAXOL AND ANALOGUES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-11-07 | — | — | WO | disclosed |
| EP-0722945-A1 | 9-oxo-1-azabicyclo(5.2.0)non-2,3-diene-2-carboxylic acid derivatives as antibiotics | ZENECA LIMITED (GB) | 1996-07-24 | — | — | EP | disclosed |
| US-5527924-A | ANTICARCINOGENIC AGENTS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-06-18 | — | — | US | disclosed |
| WO-1996015112-A1 | AZEPINE SYNTHESIS VIA A DIELS-ALDER REACTION | ACEA PHARMACEUTICALS, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
| US-5491152-A | Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-02-13 | — | — | US | disclosed |
| US-5488116-A | Total synthesis of taxol and analogues thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-01-30 | — | — | US | disclosed |
| US-5476933-A | Condensation, ring expansion | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) | 1995-12-19 | — | — | US | disclosed |
| EP-0369749-B1 | Anti-Tumor Compounds | KYOWA HAKKO KOGYO KK (JP) | 1995-09-27 | — | — | EP | disclosed |
| EP-0659190-A1 | ANTINEOPLASTIC HETERONAPHTHOQUINONES | BIOCHEM PHARMA INC (CA) | 1995-06-28 | — | — | EP | disclosed |
| US-5416225-A | Chemical intermediates | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1995-05-16 | — | — | US | disclosed |
| WO-1995012567-A1 | TOTAL SYNTHESIS OF TAXOL AND ANALOGUES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1995-05-11 | — | — | WO | disclosed |
| US-5371074-A | Use of saccharin derivatives as proteolytic enzyme inhibitors | STERLING WINTHROP INC. (US) | 1994-12-06 | — | — | US | disclosed |
| WO-1994011382-A1 | ANTINEOPLASTIC HETERONAPHTHOQUINONES | BIOCHEM PHARMA INC. (CA) | 1994-05-26 | — | — | WO | disclosed |
| WO-1993020036-A1 | TOTAL SYNTHESIS OF TAXOL | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1993-10-14 | — | — | WO | disclosed |
| US-5236917-A | Respiratory system disorders, antiarthritic agents | STERLING WINTHROP INC. (US) | 1993-08-17 | — | — | US | disclosed |
| EP-0542372-A1 | 2-Substituted saccharin derivative proteolytic enzyme inhibitors | STERLING WINTHROP INC. (US) | 1993-05-19 | — | — | EP | disclosed |
| US-5155240-A | Process for producing optically active dihydropyran derivative | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1992-10-13 | — | — | US | disclosed |
| US-5114945-A | Spiropiperidine derivatives | GLAXO GROUP LIMITED (GB) | 1992-05-19 | — | — | US | disclosed |
| US-5071984-A | Antitumor agent | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-12-10 | — | — | US | disclosed |
| US-4992551-A | Antitumor agents | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
| EP-0369749-A2 | Anti-Tumor Compounds | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-05-23 | — | — | EP | disclosed |
| EP-0330461-A2 | Piperidine derivatives | GLAXO GROUP LIMITED (GB) | 1989-08-30 | — | — | EP | disclosed |
| US-4783280-A | Liquid crystal mixture | HOFFMANN-LA ROCHE INC. (US) | 1988-11-08 | — | — | US | disclosed |
| US-4708441-A | LIQUID CRYSTALS | HOFFMAN-LA ROCHE INC. (US) | 1987-11-24 | — | — | US | disclosed |
| US-4550981-A | Liquid crystalline esters and mixtures | HOFFMANN-LA ROCHE INC. (US) | 1985-11-05 | — | — | US | disclosed |
| US-4460770-A | Liquid crystal mixture | HOFFMANN-LA ROCHE INC. (US) | 1984-07-17 | — | — | US | disclosed |
| US-4133816-A | Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor | ELI LILLY AND COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4115403-A | Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo [b,d]pyran-9-ones and intermediates therefor | ELI LILLY AND COMPANY (US) | 1978-09-19 | — | — | US | disclosed |
| US-4054581-A | Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor | ELI LILLY AND COMPANY (US) | 1977-10-18 | — | — | US | disclosed |
| US-4042707-A | ANALGESICS, NARCOTIC ANTAGONISTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
| JP-H00977760-A | — | — | 0001-01-01 | — | — | JP | disclosed |
| JP-H00977760-A | — | — | 0001-01-01 | — | — | JP | disclosed |